{"study_id": 62439, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of cinnamon supplementation on liver enzyme levels, specifically ALT, AST, and ALP, in adults.", "results_summary": "Cinnamon supplementation had no significant overall effect on liver enzymes but showed a reduction in ALT and AST levels in patients with type 2 diabetes, particularly with low-dose supplementation (<1,500 mg/d), longer follow-up (>12 weeks), and in elderly patients (>50 years).", "population_specificity": "Adults, with specific benefits noted in patients with type 2 diabetes and elderly individuals (>50 years).", "effective_dosage": "Low-dose (<1,500 mg/d) and unspecified higher doses.", "study_duration": "Trials with follow-up longer than 12 weeks showed significant effects.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:05.599002+00:00"}
{"study_id": 62440, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the efficacy of bioactive natural compounds, including cinnamon, on reducing homocysteine levels based on clinical trials and animal studies.", "results_summary": "Based on animal studies, cinnamon significantly reduced homocysteine levels. However, clinical trial results were not uniform, suggesting the need for more well-designed trials.", "population_specificity": "Animal models and human clinical trials (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:07.182369+00:00"}
{"study_id": 62441, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of Gynoclear\u2122, which contains Cinnamomum cassia (Chinese cinnamon), in reducing endometriosis-related pain and improving quality of life.", "results_summary": "The abstract does not provide results, as the study appears to be ongoing or not yet concluded.", "population_specificity": "Adult participants in Australia with laparoscopic confirmation of endometriosis and moderate or greater pelvic pain.", "effective_dosage": "Not specified", "study_duration": "2-month treatment period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:08.281140+00:00"}
{"study_id": 62442, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review evidence on the potential benefits of plant-derived natural products, including cinnamon, for treating or preventing non-alcoholic fatty liver disease.", "results_summary": "The abstract suggests cinnamon may have beneficial effects due to its anti-inflammatory, antioxidant, antidiabetic, insulin-sensitizing, antiobesity, hypolipidemic, and hepatoprotective properties, but specific results for cinnamon are not detailed.", "population_specificity": "Individuals with or at risk of non-alcoholic fatty liver disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:08.427808+00:00"}
{"study_id": 62443, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of cinnamon and other bioactive natural compounds on insulin resistance (IR) and related metabolic markers.", "results_summary": "The study found that cinnamon, among other herbal bioactive compounds, demonstrated efficacy in decreasing IR, fasting blood sugar (FBS), fasting insulin, and HbA1c. The abstract suggests these compounds likely work through anti-inflammatory properties.", "population_specificity": "High-risk individuals (e.g., obese populations, pre-diabetes) and general adults with metabolic concerns.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:10.359140+00:00"}
{"study_id": 62444, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the clinical evidence regarding cinnamon's effects on cardiometabolic risk factors in patients with metabolic diseases.", "results_summary": "The meta-analysis found that cinnamon significantly reduced total cholesterol, triglycerides, LDL-C, serum glucose, serum insulin, waist circumference, and blood pressure, while increasing HDL-C. The effects were particularly robust at doses \u22641.5 g.", "population_specificity": "Patients with metabolic diseases", "effective_dosage": "\u22641.5 g (specific frequency not mentioned)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:11.514073+00:00"}
{"study_id": 62445, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of cinnamon supplementation on liver enzymes (ALT, ALP, AST) through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found no significant overall effect of cinnamon on liver enzymes, but subgroup analyses showed a reduction in ALT levels at dosages <1500 mg/day, in trials lasting >12 weeks, and in mixed-gender studies.", "population_specificity": "Adults (specific demographics not detailed).", "effective_dosage": "<1500 mg/day (effective dosage for ALT reduction).", "study_duration": "Varied, with significant effects observed in trials >12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:12.570533+00:00"}
{"study_id": 62437, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate Cinnamon's potential therapeutic effects for SARS-CoV-2 infection based on Traditional Persian Medicine theories and pharmacological evidence.", "results_summary": "The study suggests Cinnamon may improve SARS-CoV-2 symptoms through anti-obstructive, anti-viral, anti-inflammatory, and antioxidant effects, aligning with Traditional Persian Medicine concepts. However, clinical evidence supporting these claims is not detailed in the abstract.", "population_specificity": "Not specified (theoretical review based on Traditional Persian Medicine and pharmacological studies).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:13.854595+00:00"}
{"study_id": 62446, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 55, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of cinnamon as an adjuvant treatment in reducing glycemic levels in people with type 2 diabetes compared to a placebo.", "results_summary": "After 90 days, the cinnamon group showed statistically significant but modest reductions in glycated hemoglobin (0.2%) and fasting venous glucose (0.55 mmol/L) compared to the placebo group.", "population_specificity": "160 people with type 2 diabetes, aged 18-80, using oral antidiabetic agents, with glycated hemoglobin \u2265 6.0%.", "effective_dosage": "3 g capsules daily", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:15.044671+00:00"}
{"study_id": 62449, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effect of cinnamon supplementation on disease activity in patients with rheumatoid arthritis (RA).", "results_summary": "Cinnamon supplementation was associated with a decrease in RA clinical activity, but the external validity of the study was limited due to methodological concerns. No conclusion on the impact of curcumin supplementation on RA activity could be drawn due to low-quality studies.", "population_specificity": "Patients with rheumatoid arthritis (RA)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:15.858251+00:00"}
{"study_id": 62447, "supplement_id": 1024, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of Cinnamomum zeylanicum essential oil in mouthwash and spray form for treating oral candidiasis compared to nystatin.", "results_summary": "C. zeylanicum showed clinical efficacy, reducing signs and symptoms of oral candidiasis (p < 0.0339) and achieving a 61% reduction in Candida spp. on oral mucosa. Participants reported a pleasant taste and few complaints.", "population_specificity": "36 individuals with oral candidiasis (probabilistic sample).", "effective_dosage": "0.5 mg/mL of C. zeylanicum essential oil.", "study_duration": "15 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:15.934886+00:00"}
{"study_id": 62448, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the anti-diabetic properties of cinnamon, particularly its potential as a natural remedy for lowering blood glucose and enhancing insulin activity.", "results_summary": "The study found that cinnamon, especially C. zeylanicum, contains cinnamaldehyde, which effectively reduces plasma blood glucose levels, enhances glucose transport and insulin signaling proteins, and regulates dyslipidaemia, comparable to metformin.", "population_specificity": "Not specified (general diabetic population implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:16.409049+00:00"}
{"study_id": 62450, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of cinnamon versus dried figs and placebo on dysmenorrhea symptoms, stress levels, and quality of life during menstrual cycles.", "results_summary": "The cinnamon group showed no significant improvement in pain severity, duration, menstrual distress, or perceived stress compared to the placebo, and had lower quality-of-life scores than the dried-fig group.", "population_specificity": "99 midwifery students", "effective_dosage": "Not specified", "study_duration": "3 menstrual cycles", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:18.085889+00:00"}
{"study_id": 62451, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effect of cinnamon supplementation on blood lipid profiles in patients with type 2 diabetes.", "results_summary": "Cinnamon supplementation significantly reduced triglycerides, total cholesterol, and LDL-C levels but had no effect on HDL-C levels in type 2 diabetes patients. Greater reductions were observed in Eastern countries and shorter-duration studies (<2 months).", "population_specificity": "Patients with type 2 diabetes (1025 participants across 16 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Varied, with comparisons between studies lasting <2 months and \u22652 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:20.268386+00:00"}
{"study_id": 62452, "supplement_id": 1024, "safety_score": "60", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to examine the potential dangers and adverse effects of cinnamon abuse, particularly focusing on inhalational and topical exposure.", "results_summary": "The study found that cinnamon oils can cause dermatitis or ulcerations upon topical application, and inhalational exposure to cinnamon powder may lead to chronic pulmonary inflammation and fibrosis due to its biopersistent cellulose fibers.", "population_specificity": "Not specified (general discussion of spice abuse, no specific demographic studied).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:20.454241+00:00"}
{"study_id": 62453, "supplement_id": 1024, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of cinnamon supplementation on insulin resistance (IR) indices, specifically HOMA-IR scores, in women with polycystic ovary syndrome (PCOS).", "results_summary": "The meta-analysis of five RCTs found that cinnamon supplementation significantly reduced HOMA-IR scores in women with PCOS, suggesting it may improve certain IR markers. However, conflicting findings from other studies were noted.", "population_specificity": "Women with polycystic ovary syndrome (PCOS)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:21.563622+00:00"}
{"study_id": 62454, "supplement_id": 1024, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of cinnamon patch (CP) treatment for alleviating symptoms of overactive bladder (OAB) compared to a placebo.", "results_summary": "Treatment with CP showed statistically significant reductions in OAB symptom scores (OABSS), patient perception of bladder condition (PPBC), and urgency severity scale (USS) compared to placebo, suggesting it may be an effective and safe complementary therapy for OAB.", "population_specificity": "66 participants (40 women and 26 men), aged 60.35 \u00b1 12.77 years, diagnosed with OAB.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:24.214490+00:00"}
{"study_id": 62455, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the impact of cinnamon supplementation on biomarkers of inflammation and oxidative stress in humans.", "results_summary": "Cinnamon supplementation significantly reduced C-reactive protein (CRP) and malondialdehyde (MDA), marginally decreased interleukin-6 (IL-6), and increased total antioxidant capacity (TAC), but did not significantly affect intercellular adhesion molecule-1 (ICAM-1).", "population_specificity": "Humans (specific population not detailed in the abstract).", "effective_dosage": "1.5 to 4 g/day", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:24.401868+00:00"}
{"study_id": 62457, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antimicrobial effects of cinnamon essential oil, extracts, and pure compounds against oral pathogens and their potential benefits in preventing and treating dental caries, periodontal disease, endodontic issues, and candidiasis.", "results_summary": "Cinnamon essential oil, extracts, and pure compounds demonstrated significant antimicrobial activity against common oral pathogens, suggesting potential benefits in preventing dental caries, periodontal disease, and treating candidiasis and endodontic infections.", "population_specificity": "Oral pathogens and biofilm (in vitro or unspecified clinical population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:24.875506+00:00"}
{"study_id": 62456, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess whether cinnamon extract coolant could reduce bacterial contamination in aerosols during dental procedures, compared to other antimicrobial coolants like chlorhexidine and povidone iodine.", "results_summary": "The study found that cinnamon extract coolant significantly reduced colony-forming units (CFUs) in aerosols during ultrasonic scaling, with results comparable to povidone iodine and slightly better than chlorhexidine. The effect size was substantial (MD -644.55 CFU), indicating strong efficacy in reducing bacterial contamination.", "population_specificity": "Dental patients undergoing ultrasonic scaling (40 participants in the cinnamon extract group).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:25.172304+00:00"}
{"study_id": 62458, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic potential of cinnamic acid derivatives from cinnamon bark in treating cancer, bacterial infections, diabetes, and neurological disorders.", "results_summary": "The study found that cinnamic acid derivatives exhibit enhanced biological efficacy, with some outperforming standard drugs in vitro, making them promising therapeutic agents for chronic or infectious diseases. The efficacy depends on the nature of substituents incorporated into cinnamic acid.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:25.993169+00:00"}
{"study_id": 62460, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the anticancer potential of various spices, including cinnamon, through in vitro, in vivo, and clinical studies.", "results_summary": "The abstract highlights cinnamon as one of the spices with potential anticancer properties, though specific findings for cinnamon are not detailed. The review suggests spices, including cinnamon, may offer antineoplastic effects.", "population_specificity": "Not specified (general review of studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:27.943661+00:00"}
{"study_id": 62461, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the role of plant-derived secondary metabolites, including cinnamon, in the treatment of diabetes mellitus.", "results_summary": "The abstract suggests cinnamon may be a favorable choice for diabetic hypertensive patients, but specific efficacy data or outcomes are not detailed. Herbal compounds like cinnamon are noted to influence diabetes, though their prescription depends on various factors.", "population_specificity": "Diabetic hypertensive patients (implied, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:29.306347+00:00"}
{"study_id": 62462, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the overall effects of cinnamon supplementation on blood pressure in adults through a systematic review and meta-analysis of randomized clinical trials.", "results_summary": "The meta-analysis found significant reductions in both systolic and diastolic blood pressure after cinnamon supplementation, particularly at dosages \u22642 g/day, for periods longer than 8 weeks, and in participants with a baseline BMI \u226530 kg/m\u00b2. However, the study noted limitations due to small sample sizes and a lack of trials focused on hypertensive populations.", "population_specificity": "Adults, with notable effects in those with a baseline BMI \u226530 kg/m\u00b2.", "effective_dosage": "\u22642 g/day", "study_duration": "Longer than 8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:30.720911+00:00"}
{"study_id": 62464, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of cinnamon supplementation on blood pressure and anthropometric indices in patients with type 2 diabetes.", "results_summary": "Cinnamon supplementation significantly reduced systolic and diastolic blood pressure in type 2 diabetes patients but had no significant effect on body weight, BMI, or waist circumference.", "population_specificity": "Patients with type 2 diabetes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:31.349534+00:00"}
{"study_id": 62463, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of cinnamon supplementation on metabolic parameters in patients with polycystic ovary syndrome (PCOS) through a systematic review and meta-analysis of clinical trials.", "results_summary": "Cinnamon supplementation showed no significant effect on body weight or BMI but significantly reduced fasting blood sugar, fasting insulin, HOMA-IR, LDL-C, total cholesterol, and triacylglycerol while improving HDL-C levels in PCOS patients.", "population_specificity": "Patients with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:32.503583+00:00"}
{"study_id": 62465, "supplement_id": 1024, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of daily cinnamon supplementation on plasma levels of NF-kB, SIRT1, hs-CRP, IL-6, and TNF-\u03b1 in type 2 diabetes patients.", "results_summary": "The study found no significant beneficial effects of cinnamon supplementation on reducing NF-kB, SIRT1, hs-CRP, IL-6, and TNF-\u03b1 levels, except for a significant difference in NF-kB levels between groups.", "population_specificity": "44 adult patients (25-70 years old) with type 2 diabetes.", "effective_dosage": "3 grams daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:34.278187+00:00"}
{"study_id": 62466, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 3 grams of cinnamon daily for 90 days could reduce glycemic and lipid levels in adults with Type 2 Diabetes Mellitus compared to placebo.", "results_summary": "The abstract does not provide results; it describes the study design and objectives. The study is ongoing or results are pending.", "population_specificity": "130 adults with Type 2 Diabetes Mellitus (hemoglobin A1c > 6.5%) using oral antidiabetic medications in Parna\u00edba, Brazil.", "effective_dosage": "3 grams per day (4 capsules daily).", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:34.479314+00:00"}
{"study_id": 62467, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of cinnamon supplementation on body weight, BMI, waist circumference, waist-hip ratio, and body fat mass through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found that cinnamon supplementation significantly reduced BMI, body weight, and waist-hip ratio, but the abstract does not provide detailed effect sizes or clinical relevance for all outcomes. The study recommends further high-quality long-term trials to confirm these findings.", "population_specificity": "1,480 participants across 21 randomized controlled trials (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:35.356364+00:00"}
{"study_id": 62468, "supplement_id": 1024, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to assess the safety and efficacy of a nasal spray containing a standardized cinnamon bark extract (IND02) for treating seasonal allergic rhinitis (SAR).", "results_summary": "The IND02 group showed significant reductions in symptom severity, improved quality of life, work productivity, and daily activities compared to placebo, with no adverse effects on clinical laboratory parameters.", "population_specificity": "Otherwise healthy men and women aged 18-75 experiencing acute SAR symptoms.", "effective_dosage": "100 \u03bcg/100 \u03bcL per nostril, twice daily.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:35.930077+00:00"}
{"study_id": 62469, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the beneficial effects of cinnamon on stress-induced ailments, focusing on its antioxidant and protective properties.", "results_summary": "The study found that cinnamon exhibits free radical scavenging activity, making it a promising therapeutic option for oxidative stress-associated diseases. However, more molecular-level studies are needed to fully understand its clinical effects.", "population_specificity": "Not specified (general review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:36.943200+00:00"}
{"study_id": 62470, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether daily cinnamon supplementation reduces plasma levels of ICAM-1 and VCAM-1 in patients with type 2 diabetes.", "results_summary": "The study found no significant difference in ICAM-1 and VCAM-1 levels between the cinnamon and placebo groups after 8 weeks, indicating cinnamon had no beneficial effect on these markers.", "population_specificity": "44 adult patients with type 2 diabetes, aged 25-70 years.", "effective_dosage": "3 g daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:38.672114+00:00"}
{"study_id": 62471, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compile and review the ethnobotanical, pharmacological, and medicinal properties of Cinnamomum (cinnamon) from existing literature.", "results_summary": "The study found that cinnamon extracts exhibit a wide range of pharmacological properties, including antimicrobial, antioxidant, anti-inflammatory, and blood sugar-lowering effects, supported by diverse phytochemical compounds. The review recommends further clinical studies to identify the most effective antibacterial applications of cinnamon.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:40.085908+00:00"}
{"study_id": 62473, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically review and synthesize evidence on the efficacy of cinnamon for treating type 2 diabetes mellitus (T2DM) and pre-diabetes patients.", "results_summary": "Cinnamon significantly reduced fasting blood glucose (FBG) and homeostatic model assessment for insulin resistance (HOMA-IR) levels compared to placebo, though high heterogeneity among studies suggests the need for further standardized trials.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM) and pre-diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:40.329943+00:00"}
{"study_id": 62474, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of TRPA1, including its activation by cinnamaldehyde from cinnamon, in inflammation-associated pain and potential therapeutic applications.", "results_summary": "The abstract indicates that cinnamaldehyde activates TRPA1, leading to hypersensitivity and inflammation, but also suggests TRPA1 as a target for anti-inflammatory and analgesic drugs.", "population_specificity": "Not specified (general review of TRPA1 in human and animal cells).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:41.921795+00:00"}
{"study_id": 62475, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the anti-cancer properties of cinnamon, particularly its effects on apoptosis-related mechanisms in cancer cells.", "results_summary": "The study highlights cinnamon's potential anti-cancer effects through its influence on apoptosis-related pathways, suggesting it may serve as a therapeutic agent in cancer treatment. However, specific clinical outcomes or statistical significance are not detailed in the abstract.", "population_specificity": "Not specified (likely in vitro or animal models, based on abstract context).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:42.352093+00:00"}
{"study_id": 62477, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to review reactive white oral lesions, including those caused by cinnamon, focusing on their clinical and microscopic findings.", "results_summary": "The abstract mentions that cinnamon can cause keratotic lesions as part of contact stomatitis, but no specific efficacy or safety results are provided.", "population_specificity": "Not specified (general discussion of oral lesions).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:42.838301+00:00"}
{"study_id": 62476, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to systematically review the effects of cinnamon on glycemic status and anthropometric indices in patients with type 2 diabetes (T2DM).", "results_summary": "Supplementation with cinnamon reduced fasting blood sugar (FBS) by -19.26 mg/dL but showed no significant changes in other glycemic parameters or anthropometric indices. The findings had high heterogeneity, requiring cautious interpretation.", "population_specificity": "Patients with type 2 diabetes (T2DM).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:44.039596+00:00"}
{"study_id": 62480, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential protective effects of cinnamon, among other spices, on atherosclerosis and atherosclerotic cardiovascular disease.", "results_summary": "The study reviewed mechanisms, epidemiological data, and clinical studies suggesting cinnamon may have protective effects against atherosclerosis, though specific results for cinnamon were not detailed in the abstract.", "population_specificity": "General population with varied dietary styles (not specified further).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:46.119319+00:00"}
{"study_id": 62479, "supplement_id": 1024, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cinnamon extract causes electrocardiographic (ECG) effects in prediabetic patients.", "results_summary": "The study found no significant differences in ECG parameters (QTc interval, QT interval, PR interval, QRS duration, and heart rate) between cinnamon extract and placebo groups at baseline, 3 months, or 6 months. Cinnamon extract did not affect electrocardiographic measures in prediabetic patients.", "population_specificity": "Prediabetic adults participating in an aggressive lifestyle therapy program.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:46.524105+00:00"}
{"study_id": 62481, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Cinnamon could effectively relieve the intensity of primary dysmenorrhea.", "results_summary": "The study found that Cinnamon significantly reduced the intensity of dysmenorrhea compared to placebo, with pain reduction being notably greater in the intervention group after both the first and second treatment cycles.", "population_specificity": "Women experiencing primary dysmenorrhea.", "effective_dosage": "1000 mg cinnamon capsules during the first 72 hours of menstruation for two cycles.", "study_duration": "Two menstrual cycles.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:48.733635+00:00"}
{"study_id": 62482, "supplement_id": 1024, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy, duration, and safety of a lip plumping product containing cinnamon, among other ingredients, in increasing lip volume.", "results_summary": "The study found that the lip plumping product, which included cinnamon, significantly improved lip fullness in most subjects 15 minutes post-application, with effects persisting for up to 1 hour. Adverse events were limited to transient tingling and heat sensations, attributed to the release of substance P by ingredients like cinnamon.", "population_specificity": "22 subjects (18 completed) enrolled in a single-center clinical trial.", "effective_dosage": "Not specified (topical application).", "study_duration": "Assessments were conducted over 4 hours post-application.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:49.676597+00:00"}
{"study_id": 62485, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the impact of cinnamyl isobutyrate (CIB), a constituent of cinnamon, on food intake and hormonal regulation of appetite in healthy volunteers.", "results_summary": "CIB, administered at 0.45 mg in a glucose solution, reduced ad libitum energy intake from a standardized breakfast and lowered postprandial plasma glucose levels.", "population_specificity": "26 healthy volunteers", "effective_dosage": "0.45 mg CIB in a 75 g glucose-water solution", "study_duration": "Short-term (single administration with 2-hour follow-up)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:50.853383+00:00"}
{"study_id": 62483, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the molecular mechanisms and weight-loss effects of cinnamon and other spices in cell models, animal models, and human subjects.", "results_summary": "Cinnamon and other spice extracts reduced lipid accumulation in fat cells and adipose tissues by regulating transcriptional factors (C/EBPs, PPAR\u03b3) and modulating lipogenesis-related enzymes (ACC, FAS, GPDH). Oral treatment induced apoptosis in fat cells, promoted thermogenesis, and decreased body weight gain in obese animal models and human participants.", "population_specificity": "Obese animal models and human participants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:50.891753+00:00"}
{"study_id": 62486, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers investigated the impact of flaxseed addition and storage on sensory attributes, bioactive concentrations, and acceptability of banana and cinnamon muffins.", "results_summary": "The study found that adding flaxseed decreased banana and cinnamon aroma and flavor in muffins. Neither flavoring nor storage significantly altered muffin attributes or acceptability.", "population_specificity": "Clinical trial participants and consumers.", "effective_dosage": "Not specified for cinnamon.", "study_duration": "Storage tested at -20 \u00b0C for 1 and 6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:52.447854+00:00"}
{"study_id": 62484, "supplement_id": 1024, "safety_score": "80", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the hypoglycemic and lipid-lowering effects of cinnamon in individuals with type 2 diabetes mellitus and summarize clinical recommendations.", "results_summary": "Cinnamon reduced fasting blood glucose (12.9 to 52.2 mg/dL) and HbA1c (0.27 to 0.83%) in type 2 diabetes patients, though lipid-lowering effects were more controversial. Some studies noted reductions in serum insulin and fat mass, but methods were deemed inaccurate.", "population_specificity": "Individuals with type 2 diabetes mellitus.", "effective_dosage": "1-6 g of cinnamon powder (species: C. cassia/aromaticum and C. zeylanicum/verum).", "study_duration": "6 to 17 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:53.560018+00:00"}
{"study_id": 62487, "supplement_id": 1024, "safety_score": "80", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to highlight the ambiguity in labeling and identification of Cinnamomum species and its implications for safety and efficacy studies.", "results_summary": "The abstract notes that confusion between true cinnamon and cassia spices generally does not pose health risks except at very high intake levels, but inadequate botanical identification in clinical studies confounds results. Pharmacopeial standards are recommended to clarify product identity and quality.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:53.572173+00:00"}
{"study_id": 62488, "supplement_id": 1024, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of cinnamon supplementation on glycemic indices, serum lipids, and adiponectin in overweight or obese women with polycystic ovary syndrome (PCOS).", "results_summary": "Cinnamon supplementation significantly improved fasting blood glucose, insulin resistance, cholesterol levels, and weight, while increasing HDL cholesterol. No significant changes were observed in serum adiponectin.", "population_specificity": "Overweight or obese women with PCOS (n=84).", "effective_dosage": "3 capsules daily (each containing 500 mg cinnamon), totaling 1500 mg/day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:54.959657+00:00"}
{"study_id": 62489, "supplement_id": 1024, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to systematically review human reports of adverse events associated with cinnamon use, both short-term and long-term.", "results_summary": "The study found that cinnamon has multiple therapeutic effects but may cause adverse events, primarily gastrointestinal disorders and allergic reactions, especially at higher doses or prolonged use. Most adverse events were self-limiting, but medicinal use requires clinical monitoring.", "population_specificity": "Human subjects in clinical trials, case reports, case series, and spontaneous reports.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:56.407783+00:00"}
{"study_id": 62490, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effect of cinnamon supplementation on anthropometric, glycemic, and lipid outcomes in patients with type II diabetes, specifically examining differences based on baseline BMI.", "results_summary": "Cinnamon supplementation improved anthropometric measures (BMI, body fat, visceral fat), glycemic indices (FPG, 2hpp, HbA1c), and lipid profiles in type II diabetes patients, with more pronounced benefits in those with higher baseline BMI (\u226527).", "population_specificity": "Patients with type II diabetes referred to the Diabetes Clinic of Yazd University of Medical Sciences.", "effective_dosage": "500 mg capsules twice daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:58.261275+00:00"}
{"study_id": 62492, "supplement_id": 1024, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate cinnamon's potential therapeutic effects on Alzheimer's disease (AD), focusing on its ability to inhibit tau protein aggregation, amyloid-\u03b2 peptide accumulation, and modulation of oxidative stress and inflammatory pathways.", "results_summary": "Cinnamon extract effectively inhibited tau accumulation and amyloid-\u03b2 aggregation in vivo and in vitro, demonstrated neuroprotective effects, and modulated oxidative stress and inflammatory pathways. However, further clinical trials are needed to confirm therapeutic safety and efficacy.", "population_specificity": "Patients with mild-to-moderate Alzheimer's disease (AD) and potential links to diabetes mellitus (DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:59.140488+00:00"}
{"study_id": 62491, "supplement_id": 1024, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the pharmacodynamic properties and safety of Cinnamomum zeylanicum (CZ) in healthy adults through a Phase I clinical trial.", "results_summary": "The study found no significant side effects or toxicity from CZ, including hepatotoxicity or anticoagulation effects. CZ demonstrated beneficial anti-hyperlipidemic effects (reduced TC and LDL-c) and blood pressure-lowering effects in healthy adults.", "population_specificity": "30 healthy adults (mean age 38.8 \u00b1 10.4 years, 50% male).", "effective_dosage": "Water extract of CZ at increasing doses: 85 mg, 250 mg, and 500 mg, administered monthly.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:00.262312+00:00"}
{"study_id": 62493, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of cinnamon powder capsules on insulin resistance, glucose and lipid profiles, and androgens in women with polycystic ovarian syndrome (PCOS).", "results_summary": "Cinnamon supplementation significantly reduced fasting insulin and insulin resistance (HOMA-IR) compared to placebo, and also lowered LDL cholesterol. No significant changes were observed in other measured outcomes.", "population_specificity": "Women diagnosed with PCOS by Rotterdam Criteria (n=66).", "effective_dosage": "1.5 g/day in 3 divided doses.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:00.573884+00:00"}
{"study_id": 62494, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers reviewed alternative products, including cinnamon bark, for treating allergic rhinitis and improving immunotherapy efficacy.", "results_summary": "The abstract mentions cinnamon bark as one of the alternative products used instead of immunotherapy for allergic rhinitis, but no specific results or effects of cinnamon are detailed.", "population_specificity": "Patients with allergic rhinitis (AR).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:00.582222+00:00"}
{"study_id": 62495, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract as a pharmaceutical agent in patients with type-2 diabetes mellitus.", "results_summary": "The abstract describes the study protocol but does not report results, as it appears to be a trial design paper rather than a results paper.", "population_specificity": "210 subjects with type-2 diabetes mellitus, stratified by age, gender, and disease severity.", "effective_dosage": "250 mg and 500 mg of cinnamon extract.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:01.668049+00:00"}
{"study_id": 62496, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of daily cinnamon intake on glycemic indicators, advanced glycation end products, and antioxidant status in type 2 diabetes patients.", "results_summary": "The study found that a daily intake of three grams of cinnamon over eight weeks influenced glycemic indicators and antioxidant status in type 2 diabetes patients, though specific results are not detailed in the abstract.", "population_specificity": "44 patients with type 2 diabetes, aged 57 \u00b1 8 years.", "effective_dosage": "3 g/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:02.897118+00:00"}
{"study_id": 62497, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the efficacy and safety profiles of cinnamon as a natural health product with antidiabetic properties for pharmacists.", "results_summary": "The study included cinnamon among NHPs with hypoglycemic effects relevant to diabetes management, but specific results for cinnamon were not detailed in the abstract. It highlighted the potential for additive hypoglycemia when used with conventional medications.", "population_specificity": "Patients with chronic diseases, particularly diabetes.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "Potential additive hypoglycemic effects when used with conventional medications.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:04.815337+00:00"}
{"study_id": 62498, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of oral cinnamon consumption on body composition and metabolic parameters in individuals with metabolic syndrome.", "results_summary": "The study found that cinnamon supplementation significantly improved fasting blood glucose, glycosylated hemoglobin, waist circumference, BMI, and other metabolic parameters compared to placebo. The prevalence of metabolic syndrome was also significantly reduced in the cinnamon group.", "population_specificity": "Asian Indians with metabolic syndrome in north India.", "effective_dosage": "3 g daily (6 capsules of 0.5 g each).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:06.158336+00:00"}
{"study_id": 62500, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to explore the major active compounds in herbs and spices, including cinnamon, and their potential industrial applications.", "results_summary": "The abstract does not provide specific findings about cinnamon's effects but highlights its historical and potential uses in food production, medicine, pharmacology, and cosmetology.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:07.363053+00:00"}
{"study_id": 62499, "supplement_id": 1024, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the beneficial role of cinnamaldehyde, a component of cinnamon, in managing diabetes and its complications, focusing on its glucolipid-lowering effects, pharmacokinetics, and safety.", "results_summary": "Cinnamaldehyde demonstrated significant glucolipid-lowering effects in diabetic animals by improving glucose uptake, insulin sensitivity, glycogen synthesis, and pancreatic function, while also addressing diabetic renal and brain disorders through multiple signaling pathways. However, potential toxicity concerns were noted.", "population_specificity": "Diabetic animals (specific species not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:07.702604+00:00"}
{"study_id": 62503, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the anti-diabetic properties of cinnamon and its potential use for prevention and management of diabetes and associated complications.", "results_summary": "The abstract suggests that cinnamon, along with other spices, has antioxidant, anti-inflammatory, and anti-diabetic properties, making it a potential dietary approach for diabetes management. However, specific results regarding cinnamon's efficacy are not detailed in the abstract.", "population_specificity": "Not specified (general discussion on diabetes mellitus).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:09.359835+00:00"}
{"study_id": 62502, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cinnamon dietary supplements had clinically meaningful effects on glycemic control (FPG and HbA1c) in adults with type 2 diabetes mellitus (T2DM).", "results_summary": "Cinnamon supplements showed modest reductions in FPG and very slight decreases in HbA1c, but only four studies met the American Diabetes Association treatment goals. Changes in placebo groups were minimal.", "population_specificity": "Adults with T2DM, some on hypoglycemic medications.", "effective_dosage": "120 to 6,000 mg/day.", "study_duration": "4 to 16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:09.463324+00:00"}
{"study_id": 62501, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of cinnamon, among other spices, in the prevention and treatment of cardiovascular diseases.", "results_summary": "The abstract suggests that cinnamon, along with other spices, has potential antioxidant, anti-inflammatory, and immunomodulatory properties that may contribute to cardiovascular health, though specific results for cinnamon are not detailed.", "population_specificity": "Not specified (general discussion on cardiovascular disease prevention).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:09.532818+00:00"}
{"study_id": 62504, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers reviewed alternative products, including cinnamon bark, for treating allergic rhinitis and improving immunotherapy efficacy.", "results_summary": "The abstract mentions cinnamon bark as one of the alternative products used instead of immunotherapy for allergic rhinitis, but no specific results or effects of cinnamon are detailed.", "population_specificity": "Patients with allergic rhinitis (general mention, no specific demographic details).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:09.836923+00:00"}
{"study_id": 62506, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to compare the amounts, forms, and claims of cinnamon in dietary supplements with clinical trial data to assess consistency and reproducibility.", "results_summary": "The study found that cinnamon was one of the most common culinary spices in dietary supplements, but label information was often incomplete, making it difficult to determine exact amounts and forms used. Clinical trials also lacked detailed composition data, complicating comparisons.", "population_specificity": "Not specified (general dietary supplement and clinical trial data)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:13.744989+00:00"}
{"study_id": 62507, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the positive effects of cinnamon phytochemicals, such as cinnamaldehyde and cinnamic acid, on the treatment and/or prevention of metabolic syndrome (MetS).", "results_summary": "The study suggests that cinnamon phytochemicals, among other nutraceuticals, may improve several components of MetS when adequately dosed, though specific outcomes for cinnamon are not detailed in the abstract.", "population_specificity": "Subjects with metabolic syndrome or borderline parameters, including those intolerant to pharmacological therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:16.109434+00:00"}
{"study_id": 62508, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether water-soluble cinnamon extract, combined with lifestyle changes, could prevent the progression from pre-diabetes to diabetes.", "results_summary": "The study protocol was designed to assess cinnamon extract's impact on diabetes prevention, hepatic transaminases, renal function, and other metabolic markers, but results were not yet available in the abstract.", "population_specificity": "428 subjects with pre-diabetes participating in a lifestyle change program.", "effective_dosage": "Not specified in the abstract.", "study_duration": "1 year of intervention, with 2 years of total follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:16.378388+00:00"}
{"study_id": 62510, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the antibacterial effects of cinnamon and summarize its history, traditional uses, phytochemical constituents, and clinical impact.", "results_summary": "The study found that cinnamon contains antibacterial compounds effective against foodborne pathogens and spoilage bacteria, supporting its use in food preservation and cosmetics. It also highlighted cinnamon's traditional medicinal uses and potential as an alternative antimicrobial strategy.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:16.981095+00:00"}
{"study_id": 62511, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of cinnamon extract, chlorhexidine mouthwash, and placebo on dental plaque levels and gingivitis.", "results_summary": "Cinnamon extract showed a reduction in plaque and gingival scores, though less than chlorhexidine and without statistical significance. The placebo group showed no change in scores.", "population_specificity": "105 healthy dental and medical students aged 21 to 25 years.", "effective_dosage": "Not specified", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:17.107921+00:00"}
{"study_id": 62512, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of cinnamon on blood glucose control, lipid profile, and BMI in patients with type 2 diabetes.", "results_summary": "Cinnamon supplementation (1 g/day) led to a significant decrease in BMI compared to placebo but showed no significant differences in blood glucose levels, insulin sensitivity, or lipid profile compared to whortleberry or placebo. However, all glucose control indices improved in the cinnamon group.", "population_specificity": "105 patients with type 2 diabetes.", "effective_dosage": "1 g/day", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:17.916703+00:00"}
{"study_id": 62509, "supplement_id": 1024, "safety_score": "70", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the experimental evidence for cinnamon's effectiveness in improving glycaemic control in animal models and humans, particularly in diabetes and pre-diabetes.", "results_summary": "Cinnamon improved glycaemic control in diabetes and pre-diabetes patients, as well as in animal models, through mechanisms like insulin receptor modulation and glucose metabolism changes. However, evidence was inconclusive, and long-term trials are needed to confirm efficacy and safety.", "population_specificity": "Patients with diabetes, pre-diabetes (IFG or IGT), and animal models.", "effective_dosage": "500 mg to 6 g per day (aqueous or powder form).", "study_duration": "40 days to 4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:18.321163+00:00"}
{"study_id": 62513, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of cinnamon tea (C. burmannii) on postprandial capillary blood glucose levels in nondiabetic adults.", "results_summary": "Cinnamon tea slightly decreased postprandial blood glucose levels and significantly lowered the maximum glucose concentration and its variation. The tea also exhibited high antioxidant capacity, likely due to polyphenol content.", "population_specificity": "Nondiabetic adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:20.860031+00:00"}
{"study_id": 62515, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the potential of cinnamon as a natural chemopreventive agent against Alzheimer's disease by modulating beta-amyloid aggregation and providing cognitive benefits.", "results_summary": "The abstract suggests cinnamon, among other herbs and spices, shows promise as a neuroprotective agent with anti-amyloidogenic activity, potentially offering cognitive benefits in aging. However, specific results for cinnamon alone are not detailed.", "population_specificity": "General aging population, particularly those at risk for cognitive decline or Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:24.512587+00:00"}
{"study_id": 62517, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of cinnamon and other natural supplements in preventing and adjunctively treating type 2 diabetes.", "results_summary": "The abstract suggests that cinnamon may help reduce the risk of type 2 diabetes and improve glycemic control in diabetics, but more long-term human trials are needed to confirm its efficacy.", "population_specificity": "Large at-risk population and type 2 diabetics.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:24.575878+00:00"}
{"study_id": 62516, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the acute and long-term effects of cinnamon, combined with kanuka honey, chromium, and magnesium, on glucose metabolism, weight, and lipid parameters in individuals with type 2 diabetes.", "results_summary": "The study found no significant improvement in glucose metabolism or glycemic control with cinnamon supplementation. However, it observed reductions in total cholesterol, LDL cholesterol, and weight, along with a trend toward increased HDL and reduced systolic blood pressure.", "population_specificity": "Individuals with type 2 diabetes (n=12)", "effective_dosage": "53.5 g of formulated honey (containing cinnamon, chromium, and magnesium) daily", "study_duration": "40 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:25.386194+00:00"}
{"study_id": 62514, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the mechanisms and clinical evidence of natural products, including cinnamon, for treating diabetes and its comorbidities.", "results_summary": "The abstract highlights cinnamon as one of the natural products reviewed for its antidiabetic effects, including mechanisms like inhibition of \u03b1-glucosidase and \u03b1-amylase, effects on glucose uptake, and reduction of oxidative stress. However, specific results for cinnamon are not detailed in the abstract.", "population_specificity": "Not specified (general review of studies on medicinal plants and natural products for diabetes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:25.665836+00:00"}
{"study_id": 62518, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the hypoglycemic effects and safety of Cinnamon as a complementary treatment for diabetes.", "results_summary": "Clinical trials on Cinnamon showed conflicting results regarding its hypoglycemic effects, with challenges in comparison due to heterogeneity in study designs, subject baselines, and endpoints. No definitive conclusions were drawn due to short study durations and small sample sizes.", "population_specificity": "Not specified (general diabetes population inferred)", "effective_dosage": "Not available", "study_duration": "Short (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:27.154214+00:00"}
{"study_id": 62519, "supplement_id": 1024, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the acute effect of a Ceylon cinnamon hydro-alcoholic extract (CCE) on carbohydrate digestion and post-meal blood glucose reduction.", "results_summary": "CCE inhibited pancreatic alpha-amylase activity in vitro and reduced glycemic response in rats dose-dependently. In humans, 1 g of CCE lowered postprandial glycemia by 14.8% (0-120 min) and 21.2% (0-60 min) without stimulating insulin secretion.", "population_specificity": "18 healthy female and male volunteers.", "effective_dosage": "1 g of CCE (single dose).", "study_duration": "Acute (2-hour post-meal monitoring).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:27.396238+00:00"}
{"study_id": 62520, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to assess the effect of cinnamon on reducing perineal pain and improving healing of episiotomy incisions in postpartum women.", "results_summary": "The cinnamon group showed significantly lower pain scores at 4-8 hours and 10-11 days post-intervention, as well as significantly better wound healing scores at 8 hours and 10-11 days compared to the placebo group.", "population_specificity": "144 postpartum women who underwent episiotomy.", "effective_dosage": "2 mL of cinnamon ointment applied every 12 hours.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:28.740838+00:00"}
{"study_id": 62521, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether cinnamon supplementation improves menstrual cyclicity and metabolic dysfunction in women with polycystic ovary syndrome (PCOS).", "results_summary": "Cinnamon supplementation (1.5 g/d) improved menstrual cyclicity compared to placebo, with more frequent cycles observed in the cinnamon group. However, no changes in insulin resistance or serum androgen levels were noted in either group.", "population_specificity": "Women with polycystic ovary syndrome (PCOS)", "effective_dosage": "1.5 g/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:32.453959+00:00"}
{"study_id": 62523, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore whether Cinnamon, as a TLR4 antagonist, could be effective in treating LP&P-induced chronic inflammatory and oxidative/nitrosative stress illnesses like CFS.", "results_summary": "The study suggests that Cinnamon may have efficacy in treating LP&P-induced illness by antagonizing the TLR4 complex, potentially mitigating chronic inflammatory and oxidative/nitrosative stress responses. However, no direct clinical results or statistical evidence are provided in the abstract.", "population_specificity": "Vulnerable individuals exposed to LP&P emissions, particularly those developing chronic fatigue syndrome (CFS) or related conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:34.065671+00:00"}
{"study_id": 62522, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of glutathione (GSH) in cellular health and the potential of cinnamon as a therapeutical intervention to increase GSH concentrations in vivo.", "results_summary": "The abstract suggests that cinnamon, among other phytochemicals, may help increase GSH levels, which are crucial for immune function, oxidative stress regulation, and mitochondrial survival, particularly in neuroimmune disorders. However, specific efficacy data on cinnamon alone are not detailed.", "population_specificity": "General discussion on cellular and neuroimmune disorders (e.g., depression, chronic fatigue syndrome, Parkinson's disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:34.066311+00:00"}
{"study_id": 62524, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether cinnamon supplementation could improve insulin sensitivity and oxidative stress markers in patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "The study found that daily cinnamon supplementation (1500 mg) significantly improved several NAFLD-related markers, including insulin resistance, lipid profiles, liver enzymes, and inflammation, but did not affect high-density lipoprotein levels. Low-density lipoprotein levels decreased in both groups.", "population_specificity": "Fifty patients with NAFLD.", "effective_dosage": "1500 mg daily (two 750 mg capsules).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:34.125750+00:00"}
{"study_id": 62505, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of cinnamon on metabolic syndrome features, particularly its impact on blood glucose levels.", "results_summary": "The study found that cinnamon supplementation reduced blood glucose in patients with metabolic syndrome, though it did not address all features of the condition. No significant antioxidative or anti-inflammatory effects were noted.", "population_specificity": "Patients with metabolic syndrome", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:34.355315+00:00"}
{"study_id": 62525, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not focus on determining cinnamon's effects but mentions it as a potential dietary allergen linked to orofacial granulomatosis (OFG).", "results_summary": "The abstract suggests cinnamon is a proposed dietary allergen associated with orofacial granulomatosis (OFG) and cheilitis granulomatosa (CG), but no specific study results on cinnamon's effects are provided.", "population_specificity": "Patients with orofacial granulomatosis (OFG) or cheilitis granulomatosa (CG).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:35.264541+00:00"}
{"study_id": 62526, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate cinnamon's effects on glycemia and lipid levels in patients with type 2 diabetes through an updated systematic review and meta-analysis of RCTs.", "results_summary": "Cinnamon significantly reduced fasting plasma glucose, total cholesterol, LDL-C, and triglyceride levels while increasing HDL-C levels, but had no significant effect on hemoglobin A1c. High heterogeneity among studies limits generalizability of the results.", "population_specificity": "Patients with type 2 diabetes.", "effective_dosage": "120 mg/d to 6 g/d.", "study_duration": "4 to 18 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:35.626838+00:00"}
{"study_id": 62527, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of short-term cinnamon administration on blood pressure regulation in patients with prediabetes and type 2 diabetes through a meta-analysis of randomized, placebo-controlled trials.", "results_summary": "The study found that cinnamon significantly reduced systolic blood pressure by 5.39 mm Hg and diastolic blood pressure by 2.6 mm Hg. However, the authors caution that more long-term, large-scale studies are needed before recommending cinnamon for blood pressure control.", "population_specificity": "Patients with prediabetes and type 2 diabetes.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Short-term (exact duration not specified in the abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:37.591610+00:00"}
{"study_id": 62528, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of cinnamon as a nutraceutical in addressing multiple components of metabolic syndrome (MetS).", "results_summary": "The abstract suggests that cinnamon has clinically demonstrated effects on more than one component of MetS, indicating potential benefits for metabolic health, though specific results are not detailed.", "population_specificity": "Subjects with metabolic syndrome (MetS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:39.613325+00:00"}
{"study_id": 62531, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review substances, including cinnamon extract, that may attenuate TLR4-mediated inflammation and oxidative stress, potentially treating various inflammatory disorders.", "results_summary": "The study identified cinnamon extract as one of the promising agents capable of acting as a TLR4/MyD88 antagonist, potentially reducing inflammation and oxidative stress linked to TLR4 activation.", "population_specificity": "Not specified (general review of TLR4-related diseases)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:41.787364+00:00"}
{"study_id": 62533, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the antibacterial effectiveness of cinnamon oil and clove oil against oral microbiota causing dental caries.", "results_summary": "Cinnamon oil demonstrated superior antibacterial activity compared to clove oil, inhibiting all ten test bacterial species involved in dental caries, with a maximum inhibition zone diameter of 24.0 mm against Streptococcus mutans. The study suggests cinnamon oil may be more effective than clove oil for treating dental caries.", "population_specificity": "Oral microbiota (bacterial species causing dental caries)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:42.934011+00:00"}
{"study_id": 62532, "supplement_id": 1024, "safety_score": "85", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of cinnamon on glycemic control in patients with type 1 or type 2 diabetes mellitus.", "results_summary": "The study found no statistically significant difference in fasting blood glucose, HbA1c, serum insulin, or postprandial glucose between cinnamon and control groups. Adverse reactions were infrequent and generally mild.", "population_specificity": "Patients with type 1 or type 2 diabetes mellitus (total of 577 participants).", "effective_dosage": "Mean dose of 2 g daily (predominantly Cinnamomum cassia).", "study_duration": "4 to 16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:43.189340+00:00"}
{"study_id": 62530, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to trace the transmission of ethnopharmacological knowledge about Cinnamon from Eastern (Indian and Chinese) to Mediterranean traditions.", "results_summary": "The study noted that Cinnamon's Eastern origin was known, but its exact area was not always clear. Therapeutic uses in the Mediterranean did not correspond to those in its area of origin, though some knowledge of original uses was preserved.", "population_specificity": "Historical pharmacological traditions (5th century B.C.E. to 16th century)", "effective_dosage": "Not available", "study_duration": "Not applicable (historical study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:43.276061+00:00"}
{"study_id": 62529, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to develop and assess a low phenolic acid diet (including cinnamon restriction) as a potential treatment for orofacial granulomatosis (OFG).", "results_summary": "The low phenolic acid diet improved disease severity in 7 of 10 patients, with significant improvement in mean severity scores from week 0 to 6, and maintained effects in some patients during reintroduction.", "population_specificity": "Patients with orofacial granulomatosis (OFG).", "effective_dosage": "Not specified (dietary restriction of phenolic acids, including cinnamon).", "study_duration": "6 weeks of exclusion, followed by 6 weeks of reintroduction.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:44.000531+00:00"}
{"study_id": 62534, "supplement_id": 1024, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether cinnamon supplementation could improve blood glucose control in Chinese patients with type 2 diabetes.", "results_summary": "The study found that both low-dose (120 mg/d) and high-dose (360 mg/d) cinnamon extract significantly reduced hemoglobin A(1c) and fasting blood glucose levels compared to placebo. Blood triglyceride levels were also significantly reduced in the low-dose group, while other lipid and liver markers remained unchanged.", "population_specificity": "Chinese patients with type 2 diabetes (n=66).", "effective_dosage": "120 mg/d (low-dose) and 360 mg/d (high-dose) cinnamon extract.", "study_duration": "3 months.", "interactions": "Patients took gliclazide during the study, but no adverse interactions were reported.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:44.983628+00:00"}
{"study_id": 62535, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-fungal mechanisms and curative effects of cinnamon oil and pogostemon oil complexes against intestinal Candida infections.", "results_summary": "The study found that cinnamon oil and pogostemon oil complexes exhibited strong anti-fungal effects against Candida species, damaging cell structures and leading to cell death. Treatment resulted in a 71.67% curative ratio and 28.33% improvement ratio in infected patients.", "population_specificity": "Sixty intestinal Candida-infected patients.", "effective_dosage": "Not specified (only MIC values provided: 0.064 mg/mL for cinnamon oil against Candida albicans).", "study_duration": "Not specified (morphological changes observed over 24-72 hours; patient treatment duration not detailed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:47.147151+00:00"}
{"study_id": 62536, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of cinnamon on glycaemic control in patients with Type 2 Diabetes mellitus.", "results_summary": "Meta-analysis of six clinical trials showed a significant decrease in mean HbA1c (0.09%) and mean FPG (0.84 mmol/l), indicating cinnamon's beneficial effect on glycaemic control in the short term (<4 months).", "population_specificity": "Patients with Type 2 Diabetes mellitus (435 participants across 6 trials).", "effective_dosage": "1 g to 6 g per day.", "study_duration": "40 days to 4 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:48.238166+00:00"}
{"study_id": 62537, "supplement_id": 1024, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of cinnamon extract in decreasing serum glucose levels as part of an integrative cancer care protocol.", "results_summary": "The study reported that cinnamon extract decreases serum glucose levels, suggesting potential benefits for metabolic regulation. No specific data on the magnitude or statistical significance of this effect were provided in the abstract.", "population_specificity": "Patients undergoing integrative cancer care (specific details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:49.533145+00:00"}
{"study_id": 53200, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between BDNF levels, obstructive sleep apnea (OSA), and the effects of CPAP treatment.", "results_summary": "The study found no significant difference in BDNF levels between OSA patients and controls, nor any significant effect of CPAP treatment on BDNF levels, suggesting BDNF is not a useful biomarker for OSA or CPAP response.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:57.412060+00:00"}
{"study_id": 53197, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Continuous Positive Airway Pressure (CPAP) on testosterone levels and its potential role in mitigating metabolic harm from sleep loss.", "results_summary": "The abstract suggests that CPAP therapy may have an effect on testosterone levels, contrary to previous underpowered studies, but conclusive evidence is lacking. High-dose testosterone therapy can induce OSA, but physiological dosing may not.", "population_specificity": "Individuals with obstructive sleep apnea (OSA), particularly those with lower testosterone levels.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:58.192662+00:00"}
{"study_id": 53203, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the evidence and cost-utility of High-Flow Nasal Cannula (HFNC) compared to Continuous Positive Airway Pressure (CPAP) in infants with moderate-severe bronchiolitis in Colombia.", "results_summary": "CPAP showed a lower risk of intubation compared to HFNC (relative risk 0.62; 95% confidence interval 0.46-0.84) and was found to be cost-effective for treating moderate-severe bronchiolitis in infants. The study suggests CPAP should be prioritized in clinical guidelines.", "population_specificity": "Infants with moderate-severe bronchiolitis in Colombia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:58.773967+00:00"}
{"study_id": 53204, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of CPAP therapy on left ventricular hypertrophy in patients with obstructive sleep apnea syndrome and type 2 diabetes mellitus.", "results_summary": "The study found that good adherence to CPAP therapy (\u22654 h/day) led to regression of left ventricular hypertrophy, while non-adherence (<4 h/day) resulted in hypertrophic tendencies. The effects were more pronounced in severe cases with an apnea hypopnea index \u226530.", "population_specificity": "Patients with obstructive sleep apnea syndrome and type 2 diabetes mellitus (n = 123).", "effective_dosage": "CPAP \u22654 h/day (good adherence group), CPAP <4 h/day (non-adherence group).", "study_duration": "3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:58.844911+00:00"}
{"study_id": 53201, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine if the RAM cannula was non-inferior to short binasal prongs (SBP) in delivering nasal continuous positive airway pressure (CPAP) to preterm infants with respiratory distress syndrome (RDS).", "results_summary": "The study found that RAM cannula was not non-inferior to SBP for CPAP delivery, with similar CPAP failure rates but significantly less nasal trauma and a shorter CPAP duration in the RAM cannula group. No differences were observed in other adverse events.", "population_specificity": "Preterm infants (28-34 weeks gestational age) with RDS requiring CPAP as primary respiratory support.", "effective_dosage": "Not specified", "study_duration": "72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:59.133493+00:00"}
{"study_id": 53199, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of repeated less invasive surfactant administration (re-LISA) in avoiding nasal continuous positive airway pressure failure (CPAP-F) and compare outcomes to surfactant retreatment via endotracheal intubation.", "results_summary": "Re-LISA reduced CPAP-F and was associated with a lower risk of death or bronchopulmonary dysplasia (BPD) compared to intubation. Infants failing CPAP after re-LISA had similar outcomes to those intubated for the second surfactant dose.", "population_specificity": "Preterm infants with gestational age <32 0/7 weeks requiring a second surfactant dose.", "effective_dosage": "Not specified", "study_duration": "Outcomes assessed within the first 72 hours of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:59.207173+00:00"}
{"study_id": 53202, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to measure changes in ventilation/perfusion (V'/Q') mismatch in preterm infants in response to individualized nasal CPAP level selection.", "results_summary": "The study found a median within-subject reduction in V'/Q' mismatch of 1.2 kPa between baseline and best CPAP levels, with best CPAP observed at a median level of 7 cm H\u2082O. The results suggest non-invasive V'/Q' measures may help identify optimal CPAP levels, but larger studies are needed.", "population_specificity": "Preterm infants (postmenstrual age 27-35 weeks, postnatal age >24 hours) receiving supplemental oxygen.", "effective_dosage": "Best CPAP levels ranged from 5-8 cm H\u2082O.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:59.375487+00:00"}
{"study_id": 53198, "supplement_id": 1048, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of b-CPAP as respiratory support for infants with bronchiolitis in a pediatric general ward and compare PICU admissions and IMV rates between HFNC and HFNC/b-CPAP treatments.", "results_summary": "The study found that b-CPAP was safe and effective for infants with bronchiolitis in a general ward, reducing PICU admissions without increasing IMV rates. Significant improvements in respiratory and heart rates, BROSJOD scores, and FiO2 needs were observed in responders within 60 minutes of therapy.", "population_specificity": "Infants aged up to 3 months with moderate-severe bronchiolitis.", "effective_dosage": "Not specified", "study_duration": "Intervention duration not explicitly stated, but data were collected before and 60 minutes after CPAP initiation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:00.010305+00:00"}
{"study_id": 53205, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of prophylactic nasal continuous positive airway pressure (CPAP) in reducing the risk of bronchopulmonary dysplasia (BPD) in preterm infants.", "results_summary": "The study found that prophylactic nasal CPAP contributed to reducing BPD risk in preterm infants, supporting its use as an evidence-based therapy. The results were part of randomized trials conducted by the Neonatal Research Network.", "population_specificity": "Preterm infants, specifically those at risk for bronchopulmonary dysplasia (BPD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:05.391171+00:00"}
{"study_id": 53206, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of a 6-week tongue elevation training program on OSA severity in patients with low adherence to Continuous Positive Airway Pressure therapy.", "results_summary": "The study found that tongue elevation training did not significantly reduce OSA severity (AHI) but improved daytime sleepiness and tongue endurance in the intervention group compared to controls.", "population_specificity": "Adults diagnosed with moderate OSA and low adherence to CPAP therapy (mean use <4 hours per night).", "effective_dosage": "Not specified (training protocol involved anterior tongue elevation strength and endurance tasks).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:06.474560+00:00"}
{"study_id": 53210, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 30, "study_goal": "The researchers aimed to investigate methods to treat and prevent abdominal distension (CPAP belly) caused by Continuous Positive Airway Pressure in preterm infants.", "results_summary": "The study presented an intervention involving abdominal support to address CPAP belly, suggesting it as a potential solution, but did not provide conclusive results on its effectiveness.", "population_specificity": "Preterm infants", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:06.751134+00:00"}
{"study_id": 53207, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to examine the association between obstructive sleep apnea (OSA) and glaucoma, as well as the effects of continuous positive airway pressure (CPAP) therapy on ophthalmological parameters.", "results_summary": "The study found an association between OSA and glaucoma, particularly with retinal nerve fiber layer (RNFL) thinning. CPAP therapy showed mixed effects on intraocular pressure (IOP), with one study reporting a rise and two others showing no increase.", "population_specificity": "316,178 adult participants with OSA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:06.884869+00:00"}
{"study_id": 53209, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between obstructive sleep apnea (OSA) and sensorineural hearing loss (SNHL) and assess the effects of continuous positive airway pressure (CPAP) therapy on SNHL.", "results_summary": "The study found that OSA was associated with worse hearing thresholds, particularly in midfrequency and high-frequency ranges, but CPAP therapy did not significantly improve midfrequency hearing thresholds.", "population_specificity": "Adults with obstructive sleep apnea (66% male; mean age, 46.6 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:07.722513+00:00"}
{"study_id": 53208, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the association between obstructive sleep apnea (OSA) and echocardiographic parameters of diastolic dysfunction (DD) and suggest the potential role of continuous positive airway pressure (CPAP) therapy in reversing or ameliorating DD.", "results_summary": "The study found that OSA was independently associated with markers of DD, including increased left atrial volume index (LAVI), left ventricular mass index, and altered mitral inflow velocities. The abstract recommends further investigation into CPAP therapy's role in addressing these effects.", "population_specificity": "Patients with OSA diagnosed via in-laboratory polysomnography or home sleep apnea testing, compared to controls without OSA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:07.898209+00:00"}
{"study_id": 53211, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) as a standard treatment for central sleep apnea (CSA) and its effectiveness compared to other therapeutic options.", "results_summary": "The study highlights CPAP as the initial standard of care for CSA, though it notes the heterogeneity of the condition and the influence of comorbid factors on treatment efficacy. Other modes of positive pressure therapy, pharmacotherapy, and device-based therapies are under investigation but not yet established as superior.", "population_specificity": "Patients with central sleep apnea, including those with heart failure, stroke, spinal cord injury, or opioid use.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:08.508994+00:00"}
{"study_id": 53212, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the feasibility and efficacy of awake prone positioning (PP) along with non-invasive ventilation (NIV), specifically helmet continuous positive airway pressure (CPAP), in COVID-19 patients with acute hypoxemic respiratory failure (AHRF).", "results_summary": "The systematic review found that awake PP with helmet CPAP was feasible and efficacious, with no adverse events reported, though only one study documented sustained oxygenation improvement after 12 hours. The included studies had moderate to serious risk of bias and heterogeneity in respiratory support methods.", "population_specificity": "COVID-19 patients with acute hypoxemic respiratory failure (AHRF), including both ICU (40%) and non-ICU (60%) settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:09.387371+00:00"}
{"study_id": 53216, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the limitations of CPAP therapy for OSA and explore alternative treatments like hypoglossal nerve stimulation (HNS) and transcutaneous electrical stimulation (TESLA).", "results_summary": "The study highlights low long-term adherence to CPAP therapy (30-60%) and presents promising efficacy and safety results for HNS and TESLA as alternative treatments for OSA.", "population_specificity": "Patients with obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:14.258598+00:00"}
{"study_id": 53215, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between OSA and PD symptoms, as well as the inconsistent findings on CPAP therapy's effect on motor and cognitive symptoms in PD.", "results_summary": "The study found that OSA is associated with severe motor and cognitive symptoms at baseline, but the effect of CPAP therapy on these symptoms was inconsistent.", "population_specificity": "Patients with Parkinson's disease (PD) and sleep disturbances, including OSA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:14.324490+00:00"}
{"study_id": 53218, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the prevalence of secondary polycythemia in patients with OSA and assess the effect of CPAP therapy on hemoglobin and hematocrit levels.", "results_summary": "The study found that OSA is associated with an increased prevalence of secondary polycythemia, particularly in severe cases, and that CPAP treatment reduces both hemoglobin and hematocrit levels.", "population_specificity": "Adult patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:14.447876+00:00"}
{"study_id": 53219, "supplement_id": 1048, "safety_score": "60", "efficacy_score": 70, "quality_score": 80, "study_goal": "To compare the efficacy and safety of NCPAP, NIPPV, and NHFO in preterm infants with severe RDS after extubation.", "results_summary": "NCPAP showed higher extubation failure rates, longer gastrointestinal feeding times, more apnea episodes, and higher hospitalization costs compared to NIPPV and NHFO in infants under 32 weeks. No significant differences were observed in infants over 32 weeks.", "population_specificity": "Preterm infants with severe respiratory distress syndrome (RDS) post-extubation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:15.787251+00:00"}
{"study_id": 53217, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine if a low-dose short dexamethasone course combined with postextubation bubble CPAP could improve early extubation success and reduce mechanical ventilation duration in extremely preterm infants.", "results_summary": "The study found that the combined intervention was associated with successful early extubation (median time to extubation: 2 days) and significantly shorter total intubation duration (21 \u00b1 6 days vs. 30 \u00b1 10 days in controls). Bubble CPAP was noted to reduce complications like chronic lung disease.", "population_specificity": "Extremely preterm infants with birth weight <750 g.", "effective_dosage": "Not specified (low-dose short dexamethasone course).", "study_duration": "Not specified (short course).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:16.204131+00:00"}
{"study_id": 53220, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explain the physiologic basis and clinical applications of Continuous Positive Airway Pressure (CPAP) and compare it with other noninvasive respiratory support modalities.", "results_summary": "The abstract discusses the fundamentals and clinical literature behind CPAP but does not provide specific results on its effects. It mentions comparisons with other noninvasive modalities and clinical titration algorithms in emergency settings.", "population_specificity": "Not specified (general discussion of clinical applications).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:16.593901+00:00"}
{"study_id": 53222, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the pathophysiology of obstructive sleep apnea (OSA) and explore alternative therapies to CPAP based on disease mechanisms.", "results_summary": "The study highlights CPAP as the gold-standard treatment for OSA but suggests that personalized alternative therapies are emerging. It emphasizes the need for further research on the implementation and combination of these therapies.", "population_specificity": "Not specified (general OSA patients)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:17.061317+00:00"}
{"study_id": 53221, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of CPAP in reducing mortality from acute respiratory distress in infants aged 1-12 months in sub-Saharan Africa and compare findings with trials in Bangladesh and Malawi.", "results_summary": "CPAP reduced 2-week all-cause mortality by 60% (RR 0.40, 0.19-0.82; p=0.01) in infants with ARD, saving one life per 25 treated. The study advocates for implementation research to expand CPAP use in district hospitals.", "population_specificity": "Infants aged 1-12 months with acute respiratory distress in sub-Saharan Africa (Ghana, Bangladesh, Malawi).", "effective_dosage": "Not specified", "study_duration": "2-week follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:18.468204+00:00"}
{"study_id": 53223, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the long-term effectiveness of CPAP versus MAD in improving symptoms and quality of life in patients with mild obstructive sleep apnea.", "results_summary": "CPAP was superior to MAD in normalizing polysomnographic parameters and improving quality of life, while both treatments improved fatigue equally. Neither treatment improved daytime sleepiness, mood, or sustained attention.", "population_specificity": "Individuals aged 18-65 with mild OSA and BMI <35 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:21.685395+00:00"}
{"study_id": 53228, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare the effects of traditional breathing therapy versus CPAP on pulmonary function, daytime sleepiness, and blood pressure in college students with OSA.", "results_summary": "The study found that traditional breathing therapy improved pulmonary function parameters, reduced daytime sleepiness (measured by ESS), and modestly lowered systolic and diastolic blood pressure, suggesting comparable efficacy to CPAP.", "population_specificity": "Forty male college students with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:24.283533+00:00"}
{"study_id": 53225, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) improves cognitive function in patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP showed mild improvement in short-term memory and executive function, particularly with good adherence and short-term use, but no significant benefits were observed for long-term treatment. Overall, cognitive improvements were limited.", "population_specificity": "1,529 participants with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified (adherence measured as <4 h/night [poor] or \u22654 h/night [good]).", "study_duration": "Short-term (<8 weeks) and long-term (\u226512 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:24.961993+00:00"}
{"study_id": 53229, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "To investigate the effects of awake-prone positioning (APP) on oxygenation and physiological outcomes in non-intubated patients with COVID-19 receiving continuous positive airway pressure.", "results_summary": "The study found that APP significantly improved oxygenation parameters (SpO\u2082) and physiological outcomes in non-intubated COVID-19 patients, with most patients tolerating the intervention without serious adverse events.", "population_specificity": "Adult awake non-intubated patients with confirmed COVID-19 requiring non-rebreathing face masks or continuous positive airway pressure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:25.163656+00:00"}
{"study_id": 53224, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of low dose-short course intravenous paracetamol with a conventional dose regimen for early targeted closure of patent ductus arteriosus (PDA) in preterm infants on significant respiratory support, including continuous positive airway pressure.", "results_summary": "The study found that low dose-short course intravenous paracetamol was non-inferior to conventional dosing for PDA closure, with 92% closure in the low dose group vs. 94% in the standard dose group. Adverse effects and rescue therapies were comparable between groups.", "population_specificity": "Preterm infants <30 weeks of gestation requiring mechanical ventilation or continuous positive airway pressure with FiO\u2082.", "effective_dosage": "Low dose (10 mg/kg/dose 6 hourly for 72 hours) vs. conventional dose (15 mg/kg/dose 6 hourly for 120 hours).", "study_duration": "72 hours for low dose, 120 hours for conventional dose.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:25.181223+00:00"}
{"study_id": 53226, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effectiveness of a 6-month lifestyle intervention combined with CPAP and determine if the timing of weight loss initiation affects weight change in adults with moderate-severe OSA and obesity.", "results_summary": "The lifestyle intervention with CPAP resulted in a modest 3.7 kg weight loss after 12 months compared to CPAP alone, but the timing of the intervention did not affect outcomes. CPAP alone showed no significant change in body weight.", "population_specificity": "Adults newly diagnosed with moderate-severe OSA and above a healthy weight (mean BMI 34.1, 75% male, mean age 49.4 years).", "effective_dosage": "Not specified", "study_duration": "6-month intervention with 12-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:25.442694+00:00"}
{"study_id": 53227, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adding low health literacy-designed audio-visual educational videos to standard care improves CPAP adherence in adults with obstructive sleep apnea syndrome.", "results_summary": "At 2 months, there was no significant difference in CPAP usage between the standard care and educational video groups. However, at 12 months, the educational video group showed significantly higher CPAP usage (3.66 vs. 2.50 hours/night) and a higher probability of adequate usage.", "population_specificity": "Treatment-na\u00efve adults with obstructive sleep apnea syndrome, mean age 57 years.", "effective_dosage": "Not specified (standard care + 5 educational videos).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:25.581417+00:00"}
{"study_id": 53230, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess whether postoperative NIV or CPAP prevents PPCs compared to standard care in adults undergoing upper abdominal surgery, including high-risk patients.", "results_summary": "The study found no significant benefit of postoperative NIV/CPAP in reducing PPCs, including in high-risk patients, with very low certainty of evidence. No superior intervention approach was identified.", "population_specificity": "Adults undergoing upper abdominal surgery, including those at higher risk of PPCs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:26.287256+00:00"}
{"study_id": 53231, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness of heated humidified high-flow nasal cannula (HHHFNC) versus nasal continuous positive airway pressure (NCPAP) as post-INSURE respiratory support in preterm infants with respiratory distress syndrome (RDS).", "results_summary": "The study found no significant difference in early failure rates (mechanical ventilation within 7 days) between HHHFNC and NCPAP groups. Nasal injury was significantly less common in the HHHFNC group, with no other significant differences in outcomes.", "population_specificity": "Preterm infants >1 kg and >28 weeks gestational age with RDS requiring surfactant.", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:30.719291+00:00"}
{"study_id": 53235, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not explicitly state the study's goal regarding Continuous Positive Airway Pressure.", "results_summary": "The abstract does not provide specific results regarding Continuous Positive Airway Pressure's effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:31.280200+00:00"}
{"study_id": 53232, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the systemic effects of oral appliance therapy with CPAP as a first-line treatment for obstructive sleep apnea (OSA).", "results_summary": "The abstract highlights CPAP as the first-line treatment for OSA but notes that oral appliance therapy is a viable alternative for patients who do not comply with or refuse CPAP. It mentions a lack of studies on the systemic effects of oral appliance therapy compared to CPAP.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:32.482199+00:00"}
{"study_id": 53233, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers sought to determine the impact of OSA management with CPAP on atrial remodeling in patients with atrial fibrillation.", "results_summary": "CPAP therapy significantly improved conduction velocity, atrial voltage, and reduced complex points compared to the control group, indicating reversal of atrial remodeling. There was also a trend toward reduced atrial surface area with low voltage.", "population_specificity": "24 patients with atrial fibrillation and at least moderate OSA (AHI \u226515).", "effective_dosage": "Mean CPAP usage: 268 \u00b1 91 minutes/day.", "study_duration": "Minimum of 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:32.884089+00:00"}
{"study_id": 53234, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of High-Flow Nasal Cannula (HFNC) and Noninvasive Ventilation (NIV), including Continuous Positive Airway Pressure (CPAP), on mortality and intubation rates in COVID-19 patients with acute hypoxemic respiratory failure.", "results_summary": "The study found that mortality was lower with HFNC compared to NIV overall, but there was no difference in mortality between HFNC and NIV in the subgroup using helmet or CPAP. Future large-scale RCTs are needed to confirm these findings.", "population_specificity": "COVID-19 patients with acute hypoxemic respiratory failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:33.717675+00:00"}
{"study_id": 53236, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential link between obstructive sleep apnoea syndrome (OSAS) and diabetic foot ulcers (DFUs), as well as the impact of continuous positive airway pressure (CPAP) treatment on DFU healing.", "results_summary": "The abstract suggests that CPAP treatment may have a favorable impact on diabetic foot ulcer healing, though data is limited and further randomized controlled trials are needed to confirm this potential benefit.", "population_specificity": "Patients with obstructive sleep apnoea syndrome (OSAS) and diabetes mellitus (DM), particularly those with diabetic foot ulcers (DFUs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:34.379795+00:00"}
{"study_id": 53238, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the impact of nasal masks, nasal pillows, and oronasal masks on Continuous Positive Airway Pressure (CPAP) therapy in patients with obstructive sleep apnea.", "results_summary": "Nasal masks and nasal pillows were associated with lower residual apnea-hypopnea index, lower CPAP pressure, and higher adherence compared to oronasal masks. Nasal masks showed the lowest residual apnea-hypopnea index and highest adherence, while nasal pillows required the lowest CPAP pressure.", "population_specificity": "Patients with obstructive sleep apnea (6,378 participants across 29 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:34.732535+00:00"}
{"study_id": 53237, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of telemedicine versus standard face-to-face care for initiating CPAP treatment in remote patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP adherence in the telemedicine group was comparable to standard care (4.7 hours/night in both groups), with no differences in residual apnea-hypopnea index, symptom response, or quality of life. Telemedicine reduced healthcare costs and saved travel expenses without compromising outcomes.", "population_specificity": "Remote-dwelling adults with OSA in Western Australia (telemedicine group) and metropolitan OSA patients (standard care group).", "effective_dosage": "Not specified", "study_duration": "CPAP trial duration varied (telemedicine: 69.9 days, standard care: 37.6 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:35.057298+00:00"}
{"study_id": 53239, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of CPAP versus standard oxygen support in reducing the need for invasive mechanical ventilation in ICU patients with COVID-19-related acute hypoxemic respiratory failure.", "results_summary": "The study found no significant difference in the 28-day risk of invasive mechanical ventilation requirement between CPAP and standard oxygen support. There was also no significant difference in 60-day mortality between the groups.", "population_specificity": "ICU-admitted adults with COVID-19-related acute hypoxemic respiratory failure in France.", "effective_dosage": "Not specified (oxygenation strategy comparison, not dosage-based).", "study_duration": "Follow-up for 60 days; intervention duration not explicitly stated.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:39.665786+00:00"}
{"study_id": 53240, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the relationship between obstructive sleep apnea (OSA) severity, muscle sympathetic nerve activity (MSNA), and blood pressure (BP), and to quantify the effect of OSA treatment (including Continuous Positive Airway Pressure) on MSNA.", "results_summary": "The study found that MSNA is higher in individuals with OSA and related to severity, with OSA treatment effectively reducing both MSNA and BP. However, limited data prevented an assessment of the link between these reductions.", "population_specificity": "Individuals with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:40.273865+00:00"}
{"study_id": 53243, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to assess whether thyroidectomy could alleviate OSA symptoms and reduce CPAP use in patients with OSA.", "results_summary": "The study found no significant association between thyroidectomy and CPAP withdrawal, suggesting limited clinical improvement in OSA measures post-thyroidectomy.", "population_specificity": "221 OSA patients who underwent thyroidectomies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:40.341809+00:00"}
{"study_id": 53244, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether CPAP treatment reduces atrial fibrillation recurrence and burden after pulmonary vein isolation in patients with obstructive sleep apnea.", "results_summary": "CPAP treatment did not further reduce AF recurrence or burden compared to standard care after ablation, with both groups showing similar outcomes. PVI reduced AF burden in OSA patients, but no additional benefit was observed from CPAP.", "population_specificity": "Patients with paroxysmal atrial fibrillation and obstructive sleep apnea (AHI \u226515 events/hour).", "effective_dosage": "Not specified", "study_duration": "Follow-up period was 3-12 months after ablation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:42.529261+00:00"}
{"study_id": 53246, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of Continuous Positive Airway Pressure (CPAP) on lowering blood pressure in patients with obstructive sleep apnoea (OSA).", "results_summary": "CPAP demonstrated modest but stable blood pressure reduction in OSA patients and may be helpful as an adjunctive therapy for those with hypertension. However, MRAs and ACEIs/ARBs were more effective in reducing blood pressure.", "population_specificity": "Patients with obstructive sleep apnoea (OSA), specifically those with secondary hypertension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:42.606994+00:00"}
{"study_id": 53242, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to develop and test an algorithm to identify patients who tolerate assisted ventilation but still require ongoing mechanical ventilation, focusing on CPAP tolerance as a step in the weaning process.", "results_summary": "The algorithm successfully identified 25% of enrolled patients as ready for extubation despite clinicians predicting longer ventilation needs, with CPAP tolerance being a key step in the screening process.", "population_specificity": "Patients on mechanical ventilation in a clinical trial setting.", "effective_dosage": "CPAP at 0 cmH2O (implied as part of the tolerance trial).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:43.121491+00:00"}
{"study_id": 53247, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of continuous positive airway pressure (CPAP) on blood pressure in patients with systemic hypertension and obstructive sleep apnea (OSA).", "results_summary": "CPAP significantly reduced 24-hour, daytime, and nighttime systolic and diastolic blood pressure, as well as heart rate, in patients with hypertension and OSA, except when the follow-up period was shorter than 3 months.", "population_specificity": "Patients with systemic hypertension and obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Follow-up periods varied, with effects not observed in studies shorter than 3 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:44.415375+00:00"}
{"study_id": 53245, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether high-flow nasal cannula therapy (HFNC) was noninferior to continuous positive airway pressure (CPAP) as the first-line mode of noninvasive respiratory support for acutely ill children.", "results_summary": "HFNC met the noninferiority criterion compared to CPAP for time to liberation from respiratory support. HFNC also showed significantly lower use of sedation, shorter critical care stays, and shorter hospital stays, though CPAP had a higher rate of nasal trauma.", "population_specificity": "Acutely ill children aged 0 to 15 years requiring noninvasive respiratory support in pediatric critical care units.", "effective_dosage": "CPAP of 7 to 8 cm H2O.", "study_duration": "Intervention duration varied; median time to liberation was 47.9 hours for CPAP.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:45.021006+00:00"}
{"study_id": 53248, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of Continuous Positive Airway Pressure (CPAP) on cardiac mechanics, specifically left and right ventricular function, in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found significant improvements in both left and right ventricular global longitudinal strain (GLS) after CPAP treatment, indicating beneficial effects on biventricular function in OSA patients. However, improvements in LV ejection fraction (LVEF) and tricuspid annular plane systolic excursion (TAPSE) were less pronounced.", "population_specificity": "337 patients with obstructive sleep apnea (OSA) from nine studies.", "effective_dosage": "Not specified", "study_duration": "2-24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:48.671228+00:00"}
{"study_id": 53249, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the association between cardiorespiratory polygraphy findings (including CPAP use) and stroke mortality or ischemic event recurrence after ischemic stroke.", "results_summary": "Among patients with REI \u226530/h, increased central apnea index predicted higher mortality, but not independently. Only 21 stroke patients initiated CPAP treatment, and of those, only one had a new ischemic event.", "population_specificity": "204 ischemic stroke patients who underwent cardiorespiratory polygraphy within 48 hours of symptom onset.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 6.2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:49.075811+00:00"}
{"study_id": 53250, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cardiovascular benefits of CPAP therapy in patients with obstructive sleep apnea (OSA), focusing on its impact on left ventricular function, arterial stiffness, and atrial fibrillation.", "results_summary": "The study highlights that adherence to CPAP therapy reduces the risk of cardiovascular events in OSA patients, particularly in those with resistant hypertension or atrial fibrillation. It emphasizes the importance of timely OSA diagnosis and treatment to mitigate cardiovascular complications.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly those with cardiovascular complications such as resistant hypertension, atrial fibrillation, or nocturnal adverse cardiovascular events.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:49.143824+00:00"}
{"study_id": 53252, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the essential elements and considerations for applying respiratory support, including Continuous Positive Airway Pressure, in critically ill children.", "results_summary": "The abstract does not provide specific findings about Continuous Positive Airway Pressure's effects but indicates it is one of the noninvasive respiratory support modalities reviewed for treating critically ill children.", "population_specificity": "Critically ill children admitted to the pediatric intensive care unit.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:49.840190+00:00"}
{"study_id": 53251, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the validity of an early lung ultrasound (LUS) score in predicting the need for continuous positive airway pressure (CPAP) in newborns with gestational age \u226533 weeks presenting respiratory distress.", "results_summary": "The study found that the early LUS score was a good noninvasive predictor of the need for CPAP and surfactant administration, with high sensitivity and specificity at different time points (T0 and T1). The receiver operating characteristic analysis showed strong predictive accuracy (AUC 0.91 at T0 and 0.82 at T1).", "population_specificity": "Newborns with gestational age \u226533 weeks presenting respiratory distress within 3 hours of life.", "effective_dosage": "Not specified", "study_duration": "LUS assessments were performed within 3 hours of life (T0), at 4-6 hours (T1), and at symptom resolution (T2).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:52.919832+00:00"}
{"study_id": 53253, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify predictors of the efficacy of oral appliance therapy for obstructive sleep apnea (OSA) in adult patients, including the role of continuous positive airway pressure (CPAP) requirements.", "results_summary": "The study found that responders to oral appliance therapy were younger, had smaller neck circumferences, lower BMI, and required lower optimal CPAP levels than non-responders. The type of device did not affect outcomes, and the criterion \"AHI <10 and reduction AHI >50%\" was significant for predicting treatment success.", "population_specificity": "Adult patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:53.001068+00:00"}
{"study_id": 53255, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate CPAP adherence in bariatric surgery patients with newly diagnosed versus pre-existing OSA and its influence on postoperative outcomes.", "results_summary": "Inadequate CPAP adherence was higher in newly diagnosed OSA patients (73%) compared to pre-existing OSA patients (39%) six months post-surgery. No significant differences were found in cardiopulmonary complications or ICU admissions between the groups.", "population_specificity": "Obese patients scheduled for bariatric surgery, newly diagnosed or with pre-existing OSA.", "effective_dosage": "Not specified", "study_duration": "Preoperative period to 6 months postoperative", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:53.392843+00:00"}
{"study_id": 53254, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the feasibility of split-night polysomnography (snPSG) for diagnosing sleep-related breathing disorders (SRBD) and initiating non-invasive ventilation (NIV) in children.", "results_summary": "The study found that snPSG was technically feasible in children, facilitating SRBD diagnosis and NIV initiation, with a significant reduction in median apnea-hypopnea index (AHI) from 16.6 to 7.6 events/hour. Most children (87.2%) had moderate to severe SRBD, and treatment reduced the severity in many cases.", "population_specificity": "Children with sleep-related breathing disorders, including those with medical complexity (e.g., central nervous system, musculoskeletal/neuromuscular, and cardiac disorders).", "effective_dosage": "Not specified", "study_duration": "Single-night study (split-night PSG)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:55.779687+00:00"}
{"study_id": 53258, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to determine whether high-flow nasal oxygen (HFNO) compared to conventional oxygen therapy (COT) could prevent escalation of respiratory support in patients with COVID-19 pneumonia and mild hypoxaemia.", "results_summary": "The study found no significant difference between HFNO and COT in preventing escalation of respiratory support, clinical recovery rates, ICU admissions, or hospital length of stay.", "population_specificity": "Patients with COVID-19 pneumonia and mild hypoxaemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:57.343455+00:00"}
{"study_id": 53256, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the pathophysiology of obstructive sleep apnea (OSA) and the potential for alternative therapies to continuous positive airway pressure (CPAP) in selected patients.", "results_summary": "The abstract discusses the complex pathophysiology of OSA and its comorbidities but does not provide specific findings on CPAP's effects. It suggests a move toward precision medicine as an alternative to CPAP in some cases.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and associated comorbidities (metabolic, cardiovascular, renal, pulmonary, neuropsychiatric).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:57.616171+00:00"}
{"study_id": 53261, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review existing research on the impact of OSA on hearing and balance function and assess whether CPAP therapy affects these functions.", "results_summary": "Most studies showed increased hearing thresholds, absent OAE, and delayed ABR in adults with OSA, while CPAP transiently increased middle ear pressure. Effects on other auditory regions and the vestibular system remain unclear, and research on children is limited.", "population_specificity": "Adults and children with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:58.273538+00:00"}
{"study_id": 53260, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers compared the short-term clinical outcomes of preterm infants using two different automated oxygen controllers (OxyGenie and CLiO) to assess their impact on morbidity and NICU stay duration.", "results_summary": "The OxyGenie group had significantly fewer days on continuous positive airway pressure (8.4 vs. 16.7 days) and invasive ventilation (0 vs. 2.1 days), as well as reduced laser coagulation for ROP and shorter NICU stays compared to the CLiO group. No significant differences were found in other morbidities.", "population_specificity": "Preterm infants in a tertiary-level neonatal unit in the Netherlands.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:58.475971+00:00"}
{"study_id": 53263, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the key modes of non-invasive respiratory support, including Continuous Positive Airway Pressure, for preterm infants, focusing on their mechanisms and clinical benefits.", "results_summary": "Non-invasive respiratory support, including Continuous Positive Airway Pressure, shows modest success in reducing bronchopulmonary dysplasia incidence compared to invasive mechanical ventilation, with improved clinical practice reported in population-based studies.", "population_specificity": "Preterm infants, particularly those born before 28 weeks of gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:01.000886+00:00"}
{"study_id": 53264, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Information-Motivation-Behavioral (IMB) skills intervention could improve adherence to Continuous Positive Airway Pressure (CPAP) therapy in patients with moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS).", "results_summary": "The study found that IMB skills intervention significantly improved CPAP adherence in OSAHS patients compared to the control group, with no significant baseline differences between groups. The intervention was deemed suitable for clinical promotion.", "population_specificity": "Patients primarily diagnosed with moderate-to-severe OSAHS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:01.990705+00:00"}
{"study_id": 53262, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "To evaluate the effect of long-term CPAP treatment on disease severity of obstructive sleep apnea (OSA) in patients with a history of cardiac or cerebrovascular disease.", "results_summary": "Long-term CPAP use did not result in clinically significant changes in AHI or ODI overall but showed variable effects when stratified by OSA severity. Both CPAP and standard care groups showed reductions in AHI, but there was no significant difference between the groups.", "population_specificity": "Adults aged 45-75 years with a history of cardiac or cerebrovascular disease and confirmed OSA.", "effective_dosage": "Daily CPAP usage averaged 4.1 \u00b1 1.9 hours.", "study_duration": "48.0 \u00b1 14.5 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:02.551133+00:00"}
{"study_id": 53265, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in the multimodality treatment of Obstructive Sleep Apnea (OSA) and its adherence challenges.", "results_summary": "CPAP is considered first-line therapy for OSA but faces adherence issues. Nasal surgery can improve CPAP compliance by reducing therapeutic pressure, though its effect on the apnea-hypopnea index remains controversial.", "population_specificity": "Patients with Obstructive Sleep Apnea (OSA), including those with varying severity levels (mild to severe).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:04.110755+00:00"}
{"study_id": 53269, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to determine whether NHFOV was more effective than NCPAP or NIPPV in reducing the need for invasive mechanical ventilation (IMV) after extubation in preterm neonates.", "results_summary": "The study found that NHFOV slightly reduced the duration of IMV compared to NCPAP and NIPPV, and both NHFOV and NIPPV resulted in a lower risk of reintubation than NCPAP. All three respiratory support techniques were equally safe for preterm neonates.", "population_specificity": "Preterm neonates between 25 weeks plus 0 days and 32 weeks plus 6 days gestational age, ready for extubation.", "effective_dosage": "Not specified", "study_duration": "From first extubation until discharge", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:07.562085+00:00"}
{"study_id": 53266, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the performance and complications of superficial femoral midline catheters (SFMC) in COVID-19 patients undergoing Helmet Continuous Positive Airway Pressure (h-CPAP) for Acute Hypoxemic Respiratory Failure (AHRF).", "results_summary": "The study found that SFMC was generally safe with few immediate complications (e.g., accidental arterial puncture) but noted late complications like catheter-related infections (2.3%) and thrombosis (2.9%). The method was deemed practical for h-CPAP patients despite some risks.", "population_specificity": "COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF), including those on h-CPAP and severe cases.", "effective_dosage": "Not specified (focus was on catheter use, not CPAP dosage).", "study_duration": "Mean dwell time of SFMC was 11.1 \u00b1 9.8 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:08.164775+00:00"}
{"study_id": 53270, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of Continuous Positive Airway Pressure (CPAP) therapy on short-term and long-term outcomes in heart failure patients with sleep-disordered breathing.", "results_summary": "CPAP therapy was found to improve both short-term and long-term outcomes in heart failure patients with sleep-disordered breathing, including obstructive sleep apnea, central sleep apnea, and Cheyne-Stokes respiration. The abstract also notes that adaptive servoventilation (ASV) therapy is not recommended for low-EF heart failure patients with predominant central sleep apnea.", "population_specificity": "Patients with heart failure and sleep-disordered breathing (obstructive sleep apnea, central sleep apnea, or Cheyne-Stokes respiration).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:10.366904+00:00"}
{"study_id": 53271, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to discuss the prevalence, treatment options, outcomes, and future research directions of Cheyne-Stokes respiration (CSA-CSR) in children, building on adult sleep medicine experience.", "results_summary": "The abstract highlights the lack of data on CSA-CSR in children, suggesting under-recognition and the absence of routine polysomnographic assessment in pediatric heart failure patients. It calls for further research in this understudied area.", "population_specificity": "Children with moderate to severe heart failure and CSA-CSR.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:10.421206+00:00"}
{"study_id": 53272, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of CPAP treatment on ambulatory blood pressure in high-risk patients with moderate or severe OSA and cardiovascular disease or multiple cardiovascular risk factors, excluding those with severe sleepiness.", "results_summary": "CPAP resulted in modest improvements in blood pressure over 6 to 12 months, with a trend toward reduced 24-hour systolic BP, though the difference was not statistically significant. Nocturnal BP showed possibly larger effects, suggesting office BP measurements may underestimate CPAP's impact.", "population_specificity": "High-risk patients with moderate-severe OSA and cardiovascular disease or multiple cardiovascular risk factors, excluding those with severe sleepiness.", "effective_dosage": "Not specified", "study_duration": "6 to 12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:11.572871+00:00"}
{"study_id": 53273, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effect of an interdisciplinary weight loss and lifestyle intervention combined with CPAP therapy on OSA severity and comorbidities in men with moderate to severe OSA and overweight or obesity.", "results_summary": "The intervention group showed a 51% reduction in AHI at 8 weeks and 57% at 6 months, with 45% no longer requiring CPAP therapy at 8 weeks and 61.8% at 6 months. Greater improvements in body weight, composition, cardiometabolic risk, and quality of life were also observed in the intervention group.", "population_specificity": "Spanish men aged 18-65 with moderate to severe OSA and a BMI \u226525.", "effective_dosage": "Not specified (CPAP therapy details not provided).", "study_duration": "8-week intervention with follow-up at 6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:14.276277+00:00"}
{"study_id": 53275, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of nasal continuous positive airway pressure (nCPAP) as an intervention for reducing nocturnal gastroesophageal reflux symptoms.", "results_summary": "The study found insufficient evidence to recommend the use of nCPAP for reducing nocturnal reflux symptoms, indicating limited efficacy in this context.", "population_specificity": "Adult patients with nocturnal gastroesophageal reflux symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:15.852661+00:00"}
{"study_id": 53274, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining tolterodine with CPAP therapy is more effective than CPAP alone in treating overactive bladder symptoms in patients with moderate-to-severe obstructive sleep apnea syndrome.", "results_summary": "Combined tolterodine and CPAP therapy showed statistically significant improvements in OAB symptoms and urinary incontinence compared to CPAP alone, though no significant difference was found in total daily urine volume between the groups.", "population_specificity": "Women diagnosed with moderate-to-severe obstructive sleep apnea syndrome (OSAS) via polysomnography.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:16.118873+00:00"}
{"study_id": 53278, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of intermittent mask CPAP (ICPAP) and continuous helmet CPAP (HCPAP) on oxygenation and pulmonary complications following major abdominal surgery.", "results_summary": "The study compared ICPAP and HCPAP for postoperative pulmonary complications and oxygenation in patients undergoing major abdominal surgery, but specific results were not detailed in the abstract.", "population_specificity": "Patients undergoing open abdominal aortic aneurysm repair or pancreaticoduodenectomy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:18.078712+00:00"}
{"study_id": 53267, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the risk of Self-Induced Lung Injury (P-SILI) and ventilator-induced lung injury (VILI) by measuring esophageal pressure during Non-invasive respiratory support (NRS) application, including CPAP, in COVID-19 patients with early hypoxemic acute respiratory failure.", "results_summary": "The study found that in early COVID-19-related respiratory failure, inspiratory effort was not markedly elevated, and CPAP improved oxygenation compared to Venturi mask. CPAP and NIV reduced esophageal pressure (\u0394Pes) and maintained dynamic transpulmonary driving pressure (\u0394PLDyn) within a potentially safe range.", "population_specificity": "21 patients with early de-novo respiratory failure due to COVID-19.", "effective_dosage": "Not specified (30-minute trials of CPAP, HFNC, and NIV).", "study_duration": "30 minutes per trial.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:18.149211+00:00"}
{"study_id": 53277, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the correlation between lung ultrasound severity scores and bronchiolitis severity, including the need for respiratory support such as Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study found that 71.4% of children with both anterior and posterior subpleural consolidation required CPAP, indicating a significant correlation between lung ultrasound findings and the need for higher respiratory support. The lung ultrasound severity score also correlated significantly with the type and duration of respiratory support and hospital stay.", "population_specificity": "Children under 2 years old with bronchiolitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:18.970110+00:00"}
{"study_id": 53279, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the role of telemonitoring (TMg) in CPAP-treated obstructive sleep apnea (OSA) patients, focusing on parameter accuracy, clinical management, and therapy impacts.", "results_summary": "TMg is useful for supporting and fine-tuning CPAP efficacy and compliance in newly-diagnosed OSA patients, but limitations in device accuracy for measuring residual respiratory events and leaks exist, and privacy and cost-effectiveness concerns remain.", "population_specificity": "Newly-diagnosed obstructive sleep apnea (OSA) patients treated with CPAP.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:19.630698+00:00"}
{"study_id": 53268, "supplement_id": 1048, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether high-flow nasal cannula combined with upper-body elevation could serve as an effective alternative postoperative airway management strategy for patients with untreated obstructive sleep apnea (OSA).", "results_summary": "The study found that high-flow nasal cannula alone or combined with upper-body elevation significantly reduced the flow-based apnea hypopnea index and improved overnight oxygenation in postoperative OSA patients, with the greatest reduction seen in the combined intervention. No harmful events were observed.", "population_specificity": "Postoperative patients with moderate to severe obstructive sleep apnea (OSA).", "effective_dosage": "High-flow nasal cannula at 20 l \u00b7 min-1 with 40% oxygen concentration.", "study_duration": "First and second postoperative nights.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:23.452170+00:00"}
{"study_id": 53281, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "To determine whether heated humidified high-flow nasal cannula (HHHFNC) is noninferior to NCPAP for respiratory support in preterm neonates (GA 28-36 weeks).", "results_summary": "HHHFNC showed similar efficacy and safety as NCPAP, but noninferiority could not be conclusively proven due to the 95% CI crossing the noninferiority margin. No significant differences were found in secondary outcomes.", "population_specificity": "Preterm neonates (gestational age 28-36 weeks) with respiratory distress soon after birth.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:24.220679+00:00"}
{"study_id": 53285, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 60, "quality_score": 70, "study_goal": "To assess the efficacy and safety of CPAP compared to no CPAP or sham CPAP in infants and children up to three years of age with acute bronchiolitis.", "results_summary": "CPAP did not reduce the need for mechanical ventilation but showed a decrease in respiratory rate. The evidence was of low certainty, and effects on other outcomes (e.g., oxygen saturation, pCO\u2082, hospital stay) were inconclusive.", "population_specificity": "Infants and children up to 12 months with acute bronchiolitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:26.316518+00:00"}
{"study_id": 53284, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential benefits of SGLT2 inhibitors in treating obstructive sleep apnea (OSA) and their impact on cardiovascular morbidity and mortality.", "results_summary": "The study identified 4 manuscripts involving 475 OSA patients with T2DM, showing that SGLT2 inhibitors have potential positive impacts on OSA by targeting mechanisms involved in its pathogenesis. The conclusion suggests SGLT2 inhibitors are promising for OSA treatment but calls for further research.", "population_specificity": "OSA patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:26.796375+00:00"}
{"study_id": 53282, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine whether high-flow nasal cannula (HFNC) therapy was noninferior to continuous positive airway pressure (CPAP) as the first-line mode of noninvasive respiratory support for critically ill children following extubation.", "results_summary": "CPAP demonstrated superior efficacy, with a shorter median time to liberation from respiratory support (42.9 hours) compared to HFNC (50.5 hours). Mortality at day 180 was significantly lower with CPAP (2.4%) than HFNC (5.6%), though other secondary outcomes, including reintubation rates, showed no significant differences.", "population_specificity": "Critically ill children aged 0 to 15 years requiring noninvasive respiratory support within 72 hours of extubation.", "effective_dosage": "CPAP of 7 to 8 cm H2O.", "study_duration": "Intervention duration varied based on time to liberation from respiratory support, with follow-up until day 180.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:27.268461+00:00"}
{"study_id": 53287, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the benefits of noninvasive neurally adjusted ventilatory assist (NIV-NAVA) versus nasal continuous positive airway pressure (NCPAP) in preterm infants.", "results_summary": "The study found no significant differences in treatment failure or mortality between NIV-NAVA and NCPAP, but NIV-NAVA significantly reduced caffeine use compared to NCPAP. The evidence was insufficient to conclude clear benefits or harms of NIV-NAVA over NCPAP.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:27.734697+00:00"}
{"study_id": 53286, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if prophylactic high-flow nasal therapy (a form of low-level positive airway pressure) improves days alive and at home within 90 days post-surgery compared to standard oxygen therapy, and to assess its cost-effectiveness.", "results_summary": "The study is an ongoing adaptive trial comparing high-flow nasal therapy to standard oxygen therapy in high-risk cardiac surgery patients, with outcomes to be measured at 90 days post-surgery. No results are reported yet, but the design aims to detect a 2-day increase in days alive and at home.", "population_specificity": "High-risk cardiac surgery patients post-tracheal extubation.", "effective_dosage": "High-flow nasal therapy administered for a minimum of 16 hours post-extubation.", "study_duration": "Minimum 16 hours post-extubation, with follow-up until 90 days after surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:29.325413+00:00"}
{"study_id": 53289, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to evaluate whether helium-oxygen (heliox) reduces the need for Continuous Positive Airway Pressure (CPAP) or intubation in infants with bronchiolitis.", "results_summary": "The study found low-quality evidence that heliox does not reduce the need for CPAP or intubation, nor does it shorten hospitalization duration, but it may rapidly relieve respiratory distress symptoms based on M-WCAS scores.", "population_specificity": "Infants with bronchiolitis (560 participants across six studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:31.921912+00:00"}
{"study_id": 53280, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to compare short-term outcomes in preterm infants \u226430 weeks gestation receiving neonatal care, including CPAP, in a middle-income country (India) versus a high-income country (UK).", "results_summary": "The study found that survival rates for infants \u226428 weeks gestation were significantly lower in the Bengaluru center compared to London, with fewer mothers receiving antenatal steroids in Bengaluru. CPAP was part of the neonatal care, but specific efficacy data for CPAP alone were not highlighted.", "population_specificity": "Preterm infants \u226430 weeks gestation admitted to tertiary neonatal units in Bengaluru, India, and London, UK.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:33.058040+00:00"}
{"study_id": 53288, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the interaction among OSA, CPAP, and CV/CeV medications, and the effects of these medications on major adverse cardiac and cerebrovascular events and survival in patients with comorbid OSA and CV/CeV disease.", "results_summary": "CPAP treatment neutralized the negative effects of OSA by relieving chronic intermittent hypoxia, particularly in patients with good CPAP adherence. ACE inhibitors and nitrates were associated with decreased survival in some patient groups, but CPAP mitigated these effects.", "population_specificity": "Patients aged 45-75 years with comorbid OSA and cardiovascular/cerebrovascular disease.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 43.0 months (range 35.0-54.0 months)", "interactions": "ACE inhibitors and nitrates showed negative effects on survival in some groups, but CPAP mitigated these effects. Clopidogrel and nitrates decreased survival in the usual care group but not in the CPAP group.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:34.168020+00:00"}
{"study_id": 53290, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate sleep disorders, particularly obstructive sleep apnea (OSA), in individuals with Down syndrome and identify treatment options, including Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study found that OSA is the primary sleep disorder in individuals with Down syndrome, and CPAP is one of the main treatment options, alongside surgery and weight control. Cognitive dysfunction was noted in patients with sleep-disordered breathing, but CPAP's specific efficacy was not detailed beyond its inclusion as a treatment.", "population_specificity": "Children and adolescents with Down syndrome under 18 years of age.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:35.302302+00:00"}
{"study_id": 53292, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to investigate the associations between obstructive sleep apnea (OSA) and various ocular health conditions, as well as the potential impact of CPAP therapy on these conditions, particularly glaucoma risk and management.", "results_summary": "The study found conflicting evidence on OSA's associations with several eye diseases, including glaucoma, and highlighted the need for further investigation into CPAP's ocular hypertensive effects. It also noted reports of ocular surface complications due to poorly fitting CPAP masks.", "population_specificity": "Individuals with obstructive sleep apnea (OSA).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:35.405997+00:00"}
{"study_id": 53293, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "To compare the efficacy and safety of nebulized poractant alfa (at 200 and 400 mg/kg doses) combined with nasal continuous positive airway pressure (CPAP) versus CPAP alone in premature infants with respiratory distress syndrome.", "results_summary": "The study found no significant differences in the primary outcome (need for endotracheal surfactant and/or mechanical ventilation within 72 hours) between the intervention groups and CPAP alone. Secondary respiratory outcomes also showed no differences, and the intervention did not reduce respiratory failure likelihood.", "population_specificity": "Premature infants at 28 weeks gestation or older with diagnosed respiratory distress syndrome.", "effective_dosage": "200 mg/kg and 400 mg/kg of nebulized poractant alfa.", "study_duration": "72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:37.461506+00:00"}
{"study_id": 53294, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to compare the effectiveness of tactile stimulation versus routine handling in term and preterm infants with inadequate respiratory effort at birth, particularly those on continuous positive airway pressure.", "results_summary": "The study found a reduction in tracheal intubation in preterm infants receiving tactile stimulation compared to no stimulation (12 of 164 vs. 14 of 79, risk ratio 0.41), but the certainty of evidence was very low due to limited data and high risk of bias in one of the two eligible studies.", "population_specificity": "Preterm infants on continuous positive airway pressure with clinical indications for tactile stimulation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:38.030576+00:00"}
{"study_id": 53295, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether preoperative diagnosis and CPAP therapy reduce postoperative risks in patients with obstructive sleep apnea (OSA) and examine the impact of OSA severity on outcomes.", "results_summary": "The study found that preoperative diagnosis and CPAP use reduced postoperative respiratory and cardiac complications in OSA patients, with risks increasing with OSA severity. CPAP therapy was associated with lower odds of adverse events, though the conclusions require cautious interpretation due to data limitations.", "population_specificity": "Patients with obstructive sleep apnea (OSA) undergoing surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:40.370983+00:00"}
{"study_id": 53299, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review potential pharmacological alternatives to CPAP for treating obstructive sleep apnea (OSA).", "results_summary": "The abstract does not provide specific findings about CPAP's effects, focusing instead on pharmacological treatments for OSA.", "population_specificity": "Not specified (general OSA patients implied).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:42.269195+00:00"}
{"study_id": 53296, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of delivery room continuous positive airway pressure (CPAP) in reducing the risk of bronchopulmonary dysplasia (BPD) or mortality in preterm neonates.", "results_summary": "High certainty of evidence showed that delivery room CPAP compared with intubation with or without routine surfactant significantly reduced the risk of BPD or mortality at 36 weeks' postmenstrual age (RR, 0.80 [95% CI, 0.68-0.94]). Avoiding endotracheal tube placement with CPAP and less invasive surfactant administration also decreased the risk (RR, 0.90 [95% CI, 0.82-0.99]).", "population_specificity": "Preterm neonates at risk for bronchopulmonary dysplasia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:43.608523+00:00"}
{"study_id": 53291, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if Continuous Positive Airway Pressure (CPAP) could reduce cardiovascular stress and D-dimer levels in individuals with Marfan syndrome (MFS) and obstructive sleep apnea (OSA).", "results_summary": "CPAP effectively eliminated OSA (reducing AHI from 20\u00b117 to 3\u00b12 events/h) and was associated with reduced cardiovascular stress, though D-dimer results were not explicitly stated in the abstract.", "population_specificity": "16 individuals with Marfan syndrome (MFS) without aortic dissection (10 male, 6 female; age 36\u00b113 years; aortic diameter 4\u00b11 cm).", "effective_dosage": "Not specified", "study_duration": "Two nights (one baseline, one with CPAP)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:44.012179+00:00"}
{"study_id": 53298, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of prehospital noninvasive positive pressure ventilation (NIPPV) versus standard care in reducing intubation rates and hospital/ICU stays for adult patients with severe respiratory distress.", "results_summary": "The meta-analysis found that NIPPV significantly reduced intubation rates and shortened hospital and ICU stays compared to standard care, though it did not affect in-hospital mortality. The results suggest clinical benefits of NIPPV for severe respiratory distress.", "population_specificity": "Adult patients with severe respiratory distress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:44.418666+00:00"}
{"study_id": 53297, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in managing sleep-disordered breathing (SDB) in patients with heart failure (HF), particularly its impact on mortality and treatment outcomes.", "results_summary": "The abstract indicates limited evidence for CPAP's efficacy in improving mortality in patients with heart failure with reduced ejection fraction (HFrEF). It highlights the need for further well-designed studies to identify specific phenotypes of CSA/OSA in HF patients and determine effective therapies.", "population_specificity": "Patients with heart failure (HF) and sleep-disordered breathing (SDB), including obstructive sleep apnea (OSA) and central sleep apnea (CSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:44.545234+00:00"}
{"study_id": 53300, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of obstructive sleep apnoea (OSA) on retinal microvascular function by comparing continued CPAP use versus sham CPAP.", "results_summary": "The study found no significant effect of CPAP withdrawal and return of OSA on retinal microvascular responses, with no significant change in arteriolar response to flickering light between sham CPAP and continued CPAP groups. This suggests OSA may have different effects on macrovascular and microvascular endothelial function.", "population_specificity": "Patients with known moderate-to-severe OSA established on CPAP.", "effective_dosage": "Not specified", "study_duration": "14 nights", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:45.958690+00:00"}
{"study_id": 53301, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the comfort level of preterm infants receiving fentanyl versus no fentanyl during the LISA procedure (surfactant administration with nCPAP).", "results_summary": "Preterm infants receiving low-dose fentanyl during the LISA procedure showed significantly higher comfort (88.23% vs. 47.05%) without increased complications. No differences were observed in secondary outcomes like hsPDA, IVH, or BPD/mortality.", "population_specificity": "Preterm infants (28+0\u201333+6 weeks gestation) with respiratory distress syndrome (RDS).", "effective_dosage": "1 \u03bcg/kg intravenous fentanyl (single dose).", "study_duration": "Single administration during the LISA procedure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:47.098267+00:00"}
{"study_id": 53302, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the benefits and harms of non-invasive respiratory support, including Continuous Positive Airway Pressure (CPAP), in managing transient tachypnoea of the newborn (TTN).", "results_summary": "The evidence is very uncertain regarding CPAP's effect on reducing the duration of tachypnoea compared to free-flow oxygen therapy (MD -21.1 hours, 95% CI -22.9 to -19.3, very low certainty evidence). No clear conclusions could be drawn about its impact on the need for mechanical ventilation due to limited data.", "population_specificity": "Term (> 37 weeks' gestation) or late preterm (34 to 36 weeks' gestation) infants with TTN.", "effective_dosage": "Not specified", "study_duration": "Intervention administered within the first 48 hours of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:50.458895+00:00"}
{"study_id": 53303, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the bidirectional relationship between endocrine disorders and OSA, and assess whether CPAP treatment improves endocrine disturbances.", "results_summary": "The study found that CPAP's effects on endocrine disturbances remain unclear due to confounding factors, though treatment of underlying endocrine disorders can sometimes improve or cure OSA.", "population_specificity": "Patients with endocrine disorders (obesity, hypothyroidism, acromegaly, Cushing syndrome, type 1 and 2 diabetes) and OSA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:50.475781+00:00"}
{"study_id": 53304, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a patient-centered sleep study report (PCSR) for OSA patients and assess its impact on patient understanding and perceived physician interaction.", "results_summary": "The PCSR improved patient understanding and perceived patient-physician interaction compared to standard care, but its effect on therapy compliance requires further evaluation.", "population_specificity": "Patients with moderate to severe obstructive sleep apnoea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:50.842569+00:00"}
{"study_id": 53307, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the cardiovascular benefits of combining weight loss with CPAP compared to CPAP or weight loss alone in patients with obstructive sleep apnea.", "results_summary": "The combined therapy of CPAP and weight loss significantly reduced systolic blood pressure and triglyceride levels more than CPAP alone, but adding CPAP to weight loss did not further improve blood pressure or lipid values.", "population_specificity": "2627 patients with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:52.315820+00:00"}
{"study_id": 53305, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether CPAP treatment of obstructive sleep apnea (OSA) improves glycemic measures in patients with type 2 diabetes (T2D).", "results_summary": "CPAP treatment did not result in sustained improved glycemic control compared to sham in the intent-to-treat analysis, but greater CPAP adherence was associated with greater improvements in glycemic control, particularly with usage \u22657 hours per day.", "population_specificity": "Patients with type 2 diabetes and obstructive sleep apnea (N = 98).", "effective_dosage": "Not specified (adherence measured as percentage of days with \u22654 hours use and average hours/day of use).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:52.653589+00:00"}
